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Abstract 
 
Polymerization and depolymerization of actin filaments in cells are 
controlled in time and space, and proteins of the ADF / cofilin family are 
generally considered to play important roles in these processes.  However, 
there are still many questions about the regulatory mechanism of 
interactions between ADF/cofilin proteins and actin filaments.  For example, 
the depolymerizing activities by ADF/cofilin proteins from plants and 
Acanthamoeba are reported to depend on nucleotide that is bound to actin 
subunits in filaments, but the physiological significance and generality of 
such a control mechanism is unclear.   Asp11 is conserved in all actins, and 
interacts with β- and γ-phosphate groups of ATP through a divalent cation.  
Among the mutants of this Asp11, D11Q mutation is dominant lethal in 
yeast actin, and D11N mutation in α-actin dominantly causes congenital 
myopathy in human.  It is expected that functional analysis of dominantly 
toxic mutant actins such as these would provide useful information to 
elucidate the mechanism of interaction between cofilin and actin with a focus 
on the nucleotide state.  However, it is difficult to obtain large quantities of 
dominantly toxic mutant actins, and therefore, detailed functional analysis 
of the Asp11 mutant actins have not been performed yet.  This situation 
recently changed, since it became possible to purify relatively large amounts 
of dominantly toxic mutant actin by using a unique expression system 
developed in the laboratory that I belong to.  In this study, I first examined 
the affinity between actin filaments and human cofilin under different 
conditions of the actin-bound nucleotides.  Then, together with my 
colleagues of the laboratory, I performed detailed functional analysis of the 
D11N and D11Q mutant actins.  Based on the results, I conjectured why 
those Asp11 mutant actins show dominant toxicity, in a manner related to 
the actin-bound nucleotide state. 
 
Below is a brief outline of this thesis. 
In General Introduction, I summarized what is known about actin, 
regulation of polymerization and depolymerization of actin, and cofilin’s roles 
in those processes. 
In Chapter Ⅰ entitled “Effects of bound nucleotide on the affinity of 
actin for cofilin”, I report how the affinity between actin filaments and cofilin 
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changes when the actin-bound nucleotide state was changed experimentally.  
The experiments were carried out using a fluorescence microscope and actin 
and cofilin each labeled with two different fluorophores, respectively.  
Importantly, unlike the case with ADP-bound actin filaments, filaments 
carrying ADP and Pi hardly bound cofilin.  Furthermore, I was able to 
observe cooperative binding of cofilin to actin filaments carrying ADP.  
Cooperative binding of cofilin to actin filaments has been observed by 
electron microscopy, and the present results not only confirmed those 
electron microscopic studies with fluorescence microscopy, but also showed 
that the cooperative binding occurs in the micrometer range of lengths. 
In Chapter Ⅱ entitled “Characterization of Dominant Negative 
Asp11 Mutant Actins”, I conducted functional analyses of D11N and D11Q 
mutant actins.  These mutant actins exhibited polymerization competence 
that was similar to that of the wild-type, but depolymerization of the mutant 
filaments, as well as copolymer of the mutant and wild type actins, were 
slower than the wild type filaments, regardless of whether the 
depolymerization was spontaneous or induced by cofilin.  In addition, the 
rates of Pi release and nucleotide exchange of D11N and D11Q actins were 
measured by my colleagues of the laboratory.  Interestingly, while the 
ability to hydrolyze the bound ATP was normal, the exchange rate of bound 
nucleotide was much faster with the mutants than the wild type.  From 
these results, I speculated that Asp11 mutant actins, such as D11N and 
D11Q, become dominantly toxic because the exchange of bound nucleotide 
with ATP present in the external solution is very quick, so that the majority 
of the mutant actin subunits in filaments carry ATP and therefore does not 
bind cofilin.  This would result in a large amount of hard-to-depolymerize 
actin filaments, which would be highly toxic for the cells.  In other words, 
this study demonstrated the significance of very slow nucleotide exchange 
when actin molecules are incorporated into filaments. 
 
 Finally, General Discussion summarizes the results of Chapter Ⅰ 
and Ⅱ.  In addition, I discussed possible implication of my findings in a 
more general context of the regulation of actin cytoskeleton. 
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General Introduction 
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ACTIN 
 
Actin was discovered in 1942 from rabbit skeletal muscle as activator 
protein for myosin (Straub, 1942).  Subsequently, it was shown that actin is 
not specific to skeletal muscle, but is universally present in eukaryotic cells 
(e.g., Hatano and Oosawa, 1966).  It is now known that actin plays essential 
roles in a number of important cellular processes, including cell migration 
(reviewed by Mitchison and Cramer, (1996)), cytokinesis (reviewed by 
Glotzer, (2001)), organelle transport (reviewed by Goode et al., (2000)) and 
transcriptional regulation in nucleus (Hendzel, 2014), through interaction 
with various actin-binding proteins.  Furthermore, it is now well 
established that actin homologues are widely distributed in bacteria and 
archea (van den Ent et al., 2001).   
Rabbit skeletal muscle actin consists of 375 amino acid residues, and 
its amino acid sequence is highly conserved throughout eukaryotic actins. 
For example, sequences of rabbit skeletal actin and yeast actin are 87% 
identical.  In terms of structure (Kabsch et al., 1990), an actin molecule 
consists of large and small domains, each of which is divided into two 
subdomains, forming a large cleft between them (Fig. 1).  A 
nucleotide-binding site is located at the base of this cleft and binds ADP, 
ADP+Pi or ATP complexed with a metal ion (Mg2+ or Ca2+).  As will be 
described later, in low salt solutions, actin molecules are present as 
monomers but in physiological salt solutions, actin monomers polymerize 
and form two-stranded helical filaments. 
 
POLYMERIZATION OF ACTIN 
 
Polymerization process of actin has been investigated in detail in 
vitro.  Polymerization occurs only above a certain concentration (critical 
concentration), and can be regarded as a condensation process, much the 
same way as salt crystals grow in solution above a critical concentration 
(Kasai et al., 1962).  In vitro polymerization has been shown to proceed in 
three steps, the nucleation step, the elongation step when actin monomers 
polymerize one after the other to the ends of polymerizing filaments, and the 
steady state when dissociation and polymerization of actin monomer are 
balanced in dynamic equilibrium (Fig. 2).  In the first nucleation phase, 
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three actin monomers form an unstable trimer that serves as a 
polymerization nucleus (Pollard, 2007).  Nucleation phase is rate-limiting in 
actin polymerization under certain in vitro conditions.  In the subsequent 
elongation phase, elongations occur by addition of actin monomers to both 
ends of the growing filaments (Bonder et al., 1983).  Elongation rates at 
each end of the filament are different (Kondo and Ishiwata, 1976; Woodrum 
et al., 1975), and the faster growing end is called the “plus” end or 
“barbed”-end, owing to the characteristic binding orientation of myosin S1 
along the filament.  In contrast, the slower growing end is called the “minus” 
end or “pointed”-end.  When the concentration of free actin monomers 
decreases to the critical concentration, polymerization stage enters the 
steady state.  In this steady state, elongation of actin filaments are observed 
only at the barbed end, which is balanced by the loss of actin monomers from 
filaments at the pointed-end.  This process is called treadmilling (Wegner, 
1976).  When treadmilling occurs the concentration of actin monomers in 
solution is maintained at a critical concentration (~0.2 µM depending on the 
condition) (reviewed by Carlier, (1990)).  Due to the hydrolysis of bound 
nucleotide, structures of actin subunits at both ends are different, and the 
barbed-end is more stable than the pointed-end (discussed later).  
Accordingly, the critical concentrations at both ends of actin filaments are 
also different, and it is ~0.12 µM at the barbed-end and ~0.6 µM at the 
pointed-end (Carlier, 1990).  This difference of critical concentrations at 
both ends drives treadmilling. 
Actin monomer hydrolyzes bound ATP very slowly, and therefore, 
most of actin monomer carries ATP.  After actin monomers polymerize, 
bound ATP is hydrolyzed to ADP-Pi.  The resulting Pi is slowly released 
from actin subunits in filaments, so that older actin subunits in filaments 
carry ADP.  Therefore, actin subunits near the barbed-ends carry either 
ATP or ADP-Pi, while those near the pointed-ends have bound ADP.  Actin 
subunits with bound ATP or ADP-Pi stabilize the filament structure, while 
those with bound ADP destabilize the filaments (reviewed by Korn et al., 
(1987)).  This nucleotide-dependent difference in filament stability is the 
molecular basis for the asymmetric ends of an actin filament in the steady 
state. 
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COFILIN 
 
 Cofilin was identified as a protein involved in the depolymerization of 
actin filaments (Nishida et al., 1984).  Cofilin, together with ADF (actin 
depolymerizing factor), forms a family of proteins with a molecular mass of 
15,000-20,000, and is present in various eukaryotic cells, including plants, 
fungi and animals.  It is an essential protein for growth of yeast (Iida et al., 
1993; Moon et al., 1993) and the cellular slime molds (Aizawa et al., 1995).  
In human, there are three isoforms; muscle cofilin, non-muscle cofilin and 
ADF (Ono, 2007).  It is necessary for the development of skeletal muscle 
(Miyauchi-Nomura et al., 2012) and maintenance (Agrawal et al., 2012).   
 Cofilin is able to bind to both actin monomer and filaments.  After 
cofilin binds to actin filaments, twist of the filament increases (Galkin et al., 
2001; McGough et al., 1997), and it is suggested that the resultant strain in 
the filament is correlated with the filament severing activity of cofilin (De La 
Cruz, 2009).  Affinity of plant ADF and Acanthamoeba actophorin are 
higher for ADP-bound than for ATP-bound actin subunits in filaments, and 
for this reason, cofilin is believed to play an important role in the turnover of 
the actin cytoskeleton by selectively severing older sections of the filaments.  
Hotulainen et al. estimated that most of the cellular actin cytoskeleton is 
turned over by cofilin, and therefore, unveiling how cofilin interacts with 
actin filaments and how the process is regulated are critically important to 
understand the mechanism of actin regulation. 
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Figure 1.  Structures of an actin monomer and an actin filament.  Left; 
Crystal structure of monomeric actin in the ATP state (PDB ID: 1NWK; 
Graceffa and Dominguez, 2003) is represented in ribbon model (red).  The 
ATP molecule is shown as a stick model (blue).  The numbers indicate 
subdomains.  Right; Cryo-EM structure of an actin filament in the presence 
of phosphate (PDB ID: 3G37; Murakami et al., 2010) is edited to contain 5 
actin subunits. Each actin subunit is displayed in a different color. 
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Figure 2.  Three phases of actin polymerization.  In the nucleation phase, 
three actin monomers slowly associate to make an unstable trimer complex.  
The trimer serves as the nucleus for polymerization.  The rate of nuclei 
formation is determined by the concentration of actin monomers.  In the 
elongation phase, actin monomers bind to both ends of the growing filaments.  
In the steady state, actin monomers only bind to the barbed-ends, which is 
balanced by dissociation of actin monomers from the pointed-ends.  
Treadmilling occurs in this phase. 
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Effects of bound nucleotide on the affinity of actin for 
cofilin 
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INTORODUCTION 
 
A large number of cellular activities involve actin filaments, and this 
requires that polymerization and depolymerization of actin filaments are 
appropriately controlled spatially and temporally.  Actin itself has the 
potential to polymerize and depolymerize depending on the solution 
conditions, but the cellular concentration of actin is much higher than the 
critical concentration for polymerization and most of the actin molecules 
would be stably polymerized in the solution condition of the cytoplasm.  
Thus, cells contain various actin binding proteins to regulate polymerization 
and depolymerization of actin filaments (Pollard et al., 2000).  For example, 
cofilin is known to regulate polymerization and reorganization of actin 
filaments at the actin patch in yeast cells (Lappalainen and Drubin, 1997).  
Further, cytoskeletal dynamics, which is critical for motility of mammalian 
cells, depend on a pool of actin monomers that was maintained by the 
activity of ADF/cofilin (Hotulainen et al., 2005). 
Cofilin is an actin-binding protein that binds to both the filamentous 
and monomeric actin, or F-actin and G-actin respectively.  Cofilin bound to 
actin monomer is believed to prevent its polymerization by inhibiting the 
exchange of bound ADP to ATP (Hawkins et al., 1993; Hayden et al., 1993).  
On the other hand, cofilin that is bound to a filament accelerates 
depolymerization by severing the filament.  To support continuous cell 
movement, cofilin needs to bind to and promote disassembly of older 
filaments at the back of a lamellipodium, while not affecting newly 
polymerized filaments at the leading edge of the lamellipodium.  It is 
generally explained that this is achieved by asymmetric distribution of 
bound nucleotides in actin filaments, as follows.  Polymerization of an 
ATP-actin monomer stimulates hydrolysis of bound ATP to ADP-Pi (Wegner, 
1977).  Pi is then slowly released, and ADP-actin is eventually formed.  
Because incorporation of actin monomers to filaments occurs primarily at 
the barbed ends in cells, older ADP-actin subunits are accumulated near the 
pointed ends of filaments.  Carlier et al. (1997) and Blanchoin and Pollard 
(1999) showed by biochemical assays that plant cofilin and Ancathamoeba 
actophorin, both members of the ADF/cofilin family, prefer to bind to actin 
with bound ADP.  Thus, if mammalian cofilin also prefers to bind ADP-actin, 
this would bias binding of cofilin to older ADP-actin subunits near the 
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pointed ends of filaments.  
Electron microscopy study (Galkin et al., 2001), as well as classic 
solution binding assays (Hawkins et al., 1993; Hayden et al., 1993), 
demonstrated that cofilin binds cooperatively to actin filaments, and this 
phenomenon may be related to differential distribution of nucleotide states 
within filaments.  In the anterior region of migrating amoeba cells of 
Dictyostelium discoideum, for example, dendric network of actin filaments 
polymerized by the activity of Arp2 / 3 is disassembled by cofilin (Aizawa et 
al., 1997).  On the other hand, myosin II is enriched in the posterior region 
and drives the detachment of that portion of the cell from the substrate and 
retraction (Tsujioka et al., 2012; Yumura et al., 1984).  Therefore, I 
speculated that the differential distribution of nucleotide states of actin 
subunits is correlated with multiple different structures of actin filaments, 
and that this polymorphism of actin filaments plays an important role in 
localizing different actin binding proteins at different sites within cells. 
In view of the above, I thought that it is important to examine in 
detail the differential affinity of cofilin for actin filaments with different 
bound nucleotides.  For this purpose, I first labeled human cofilin and 
skeletal actin with fluorescent dyes of different fluorescence spectra.  As a 
source of cofilin, I used human cofilin since previous studies to show cofilin’s 
preference to bind ADP-actin used either plant (Carlier et al., 1997) or 
Acanthamoeba (Blanchoin and Pollard, 1999) ADF/cofilin protein.  I then 
observed binding of various concentrations of cofilin to actin filaments 
prepared under different nucleotide conditions using a fluorescence 
microscope. 
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EXPERIMENTAL PROCEDURES 
 
Purification of Cofilin-mCherry 
DNA of mCherry (Shu et al., 2006) was amplified by PCR using two 
primers.  After confirmation of the sequence, the DNA fragment was 
inserted at the BamHI and XbaI sites of pCold I (Takara Bio, Otsu, Japan) 
carrying a human cofilin gene (kindly provided by Dr. A. Nagasaki).  The 
resultant plasmid was used to transform Rosetta (DE3) E. coli cells 
(Novagen).  The transformed cells were inoculated in 100 ml of LB medium 
supplemented with 10 µg/ml chloramphenicol and 50 µg/mL ampicillin, and 
were shaken vigorously at 37℃ until the absorbance at 600 nm reached 0.5.  
After incubation for 30 min at 15℃, the culture was supplemented with 0.5 
mM isopropyl-thiogalactopyranoside (IPTG) and shaken overnight at 16℃. 
The E. coli cells were collected by centrifugation, and were frozen at 
-80℃.  The pellets were suspended in 5 ml Lysis Buffer (100 mM NaCl, 10 
mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (HEPES), pH 7.5) 
containing 0.1% Triton X-100.  After sonication on ice using a Branson 
Sonifier (Model GE-60), this solution was clarified by centrifugation (15,000 
rpm for 15 min at 4℃).  The supernatant was supplemented with 10 mM 
imidazole (pH 7.4) and incubated with 2 ml of Ni-NTA agarose resin (Qiagen) 
on a rotary wheel for 1 hr at 5℃.  The resin was recovered by a brief 
centrifugation at 1,000 rpm and was suspended in 15 ml Lysis Buffer that 
contained 30 mM imidazole.  This procedure was repeated three times, and 
finally the resin was suspended in 2 ml Lysis Buffer containing 500 mM 
imidazole.  The suspension was clarified by centrifugation, and the 
supernatant was dialyzed overnight against Lysis Buffer.  The purity was 
checked by SDS-PAGE (Fig. 3). 
 
Fluorescence labeling of actin by Alexa-488 
Fluorescence labeling of actin by Alexa 488 was carried out according 
to the method of Fujiwara et al. (2007).  First, skeletal muscle actin, 
prepared by the method of Spudich and Watt (1971), was polymerized while 
being dialyzed against buffer (50 mM piperazine-1,4-bis(2-ethanesulfonic 
acid) (PIPES) (pH 6.8), 100 mM KCl, 0.2 mM ATP, 0.2 mM MgCl2).  After 
being diluted to 2 mg/ml in the same buffer, F-actin was reacted overnight by 
adding 7.39 μM Alexa-Fluor 488 succinimidyl ester (Invitrogen, Tokyo, 
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Japan) from a stock solution of 60 mM in N,N-dimethylformamide.  The 
labeled F-actin was pelleted by ultracentrifugation at 75,000 rpm for 15 min 
at 4℃ (Hitachi CS-100GX Ultracentrifuge), dissolved in G-buffer (0.2 mM 
ATP, 0.2 mM CaCl2, 0.5 mM dithiothreitol (DTT), and 2 mM Tris, pH 8.0) and 
dialyzed overnight against G-buffer.  Actin fluorescently labeled was 61% of 
the total. 
 
AMP-PNP actin 
ATP and DTT in a solution of 40 μM Alexa 488 actin in G-buffer were 
removed using ion-exchange resin (Strzelecka-Golaszewska, 1973).  First, 
Dowex-1 (bed volume ~ 1 ml) in a spin column was equilibrated with 
G-buffer without DTT and ATP.  A 70 µl solution of 40 µM Alexa 488 actin 
was loaded to the column, and the actin solution was recovered by 
centrifugation (800 ×g, for 2 min).  After addition of adenosine 5′
-(β,γ-imido)triphosphate (AMP-PNP) to a concentration of 0.2 mM, the 
solution was incubated overnight on ice. 
 
Fluorescence microscope observation 
Three types of actin with bound ADP, ADP-Pi or AMP-PNP were 
polymerized as follows.  
ADP-actin: Alexa 488-actin was polymerized at 4 μM for 2 hr at 25℃ in 
Mg-buffer (25 mM imidazole, pH 6.5, 4 mM MgCl2, 25 mM KCl, 1 mM DTT). 
ADP-Pi-actin: After 2 hr of polymerization of Alexa 488-actin in Mg-buffer as 
above, 10 mM Na-phosphate (pH 7.4) was added and incubated for 2 hr.  
AMP-PNP-actin: Alexa 488-actin incubated with AMP-PNP as above was 
polymerized for 2 hr in Mg-buffer at the final concentration of 4 μM. 
Each type of actin filaments was diluted in Mg-buffer containing 
cofilin-mCherry, so that the final concentrations of Alexa-actin and 
cofilin-mCherry were 40 nM and 200, 400, 600, 800 or 1,600 nM, respectively.  
After 2 min incubation, approximately 2 µl of these solutions was placed 
between a glass slide and a coverslip, and was observed within 2 min using a 
fluorescence microscope (ECLIPS E600, Nikon) equipped with a highly 
sensitive CCD camera (ARUGUS-HiSCA, Hamamatsu Photonics). 
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RESULTS 
 
Figures 4 to 6 are fluorescence micrographs showing binding of 400, 
600, 800 or 1,600 nM cofilin-mCherry to Alexa 488-actin filaments.  Note 
that Alexa 488 fluorescence is suppressed when the Alexa 488-actin 
filaments were bound with cofilin-mCherry.  This is not due to fluorescence 
resonance energy transfer (FRET), since in bulk measurements of 
fluorescence intensity, mixing of Alexa 488-actin and cofilin-mCherry 
decreased the fluorescence intensity of Alexa, but the fluorescence intensity 
of mCherry did not rise (N. Umeki, unpublished observation).   
When ADP-bound (Fig. 4) and AMP-PNP-bound (Fig. 6) actin 
filaments were used, only weak fluorescence of cofilin-mCherry could be 
detected along small number of filaments in 400 nM cofilin-mCherry.  At 
600 nM cofilin-mCherry, stronger fluorescence of cofilin-mCherry could be 
detected along larger number of actin filaments.  When the concentration of 
cofilin-mCherry reached 800 nM, approximately 80% of the filaments were 
bound with cofilin-mCherry.  In the presence of 1,600 nM cofilin-mCherry, 
the fluorescence patterns were similar to those in the presence of 800 nM, 
but the observation became difficult due to high background fluorescence of 
cofilin-mCherry.  In contrast, when ADP-bound actin filaments were 
incubated with cofilin-mCherry in the presence of 10 mM Pi, fluorescence of 
cofilin-mCherry could be hardly detected along the filaments, even at the 
highest concentration (1,600 nM) of cofilin-mCherry tested (Fig. 5).   
Figure 7 summarizes the percentage of actin filaments with bound 
cofilin-mCherry, made by visual counting of filament images in Alexa 488 
and mCherry fluorescence channels.  Again it is evident from this graph 
that the affinity of ADP-Pi-bound actin filaments for cofilin is much lower 
compared to the other two forms of actin filaments. 
Intriguingly, in the presence of 800 or 1,600 nM cofilin-mCherry, 
there appears to be two distinct intensities of mCherry along ADP- or 
AMP-PNP-bound filaments.  Figure 8 is a representative fluorescence 
micrograph demonstrating this point.   
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DISCUSSION 
 
Effects of the nucleotide state of actin filaments on affinity for human cofilin 
The results shown in Figures 4 and 6 demonstrated that, when 
present at 600 nM or above under the current experimental conditions, 
human cofilin-mCherry binds to actin filaments carrying ADP or those 
incubated with AMP-PNP.  In contrast, in the presence of 10 mM Pi, very 
little cofilin-mCherry was observed to bind ADP-bound actin filaments even 
at the highest concentration of cofilin-mCherry tested (Fig. 5).  Under this 
condition, most of the ADP-bound actin subunits in filaments presumably 
bound Pi, since Kd of ADP-actin for Pi is approximately 1.5 mM (Carlier and 
Pantaloni, 1988); several fold lower than the concentration of Pi in the 
solution.  Therefore, I interpreted this result to mean that human cofilin 
has very low affinity for actin subunits carrying ADP-Pi, consistent with the 
previous reports that used either plant (Carlier et al., 1997) or 
Acanthamoeba (Blanchoin and Pollard, 1999) ADF/cofilin protein.  In cells, 
including mammalian cells, it is speculated that cofilin plays important role 
in remodeling of the actin cytoskeleton by selectively binding and severing 
older actin filaments (Pollard et al., 2000).  It is generally believed that this 
cofilin’s preference to sever older filaments is based on preferential binding 
of cofilin to actin subunits carrying ADP, over those carrying ADP and Pi.  
This is because, in the cytoplasm, in which Pi concentration is ~ 2 mM (Burt 
et al., 1977), Pi is slowly released from actin subunits carrying ADP and Pi. 
AMP-PNP is a commonly used non-hydrolyzable analog of ATP 
(Yount et al., 1971), and therefore, if AMP-PNP is bound at the ATP binding 
site of actin, that actin molecule is expected to stay in the ATP-bound state.  
If those AMP-PNP-bound actin monomers polymerize, the entire filament is 
expected to mimic the ATP-bound state.  It was therefore surprising that 
cofilin-mCherry bound to filaments incubated with AMP-PNP as well as to 
those carrying ADP (Fig. 6).  Since AMP-PNP is not a faithful mimic of ATP, 
it is possible that actin subunits with bound AMP-PNP actually behaved like 
an ADP-bound form.  However, a more likely explanation is that AMP-PNP 
was released from actin subunits during incubation with cofilin-mCherry, 
since 40 µM Alexa 488-actin solution containing 0.2 mM AMP-PNP was 
diluted 10-fold in the reaction mixture so that the concentration of AMP-PNP 
in the reaction mixture was 20 µM, which is roughly the same as the Kd of 
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actin for AMP-PNP (Cooke, 1975).  Furthermore, binding of cofilin might 
accelerate or promote the release of bound AMP-PNP in a cooperative 
manner, as it does to Pi that is bound to actin filaments (Suarez et al., 2011).  
To distinguish between these two possibilities, it would be necessary to 
repeat the experiment in the presence of a high concentration of AMP-PNP 
in the reaction mixture. 
 
Cooperative binding 
In this study, I was able to observe cooperative binding of human 
cofilin to actin filaments by fluorescence microscopy.  Cooperative binding of 
cofilin to actin filaments was first suggested by solution binding experiments 
in which the fraction of actin-bound cofilin showed a sigmoidal dependence 
on the cofilin concentration (Hawkins et al., 1993; Hayden et al., 1993).  
More recently, cooperative binding of cofilin to actin filaments was directly 
observed by electron microscopy (Galkin et al., 2001).  Cofilin forms dense 
clusters along actin filaments, while leaving other parts of the filament 
unbound.  The present study extended this finding and showed that the 
cooperative binding occurs in a range of micrometers along actin filaments.  
Recently, a similar fluorescence microscopic study using yeast cofilin was 
published (Suarez et al., 2011), and Suarez et al.’s results are largely 
consistent with my results presented here. 
Intriguingly, it appears that there are two types of cooperative 
binding between human cofilin and actin filaments, weak and strong, as 
shown in Figure 8.  The simplest interpretation of this phenomenon is that 
there are two densities of cofilin molecules in clusters; in the “weak” 
cooperativity, cofilin binds sparsely in clusters, and in the “strong” 
cooperativity, cofilin binds at full density (1:1 molar ratio with respect to 
actin subunits) in the clusters.  Because Suarez et al. (2011) did not mention 
such two different modes of cooperative binding, this may be specific to 
human cofilin or to some subtle differences in our experimental conditions.  
However, it is possible that the brighter portion may represent bundling of 
filaments, since in the presence of high concentration of cofilin, a larger 
number of severed filament fragments are produced, and those filament 
fragments may associate with one another while in solution.  To exclude 
this possibility, I tried to improve the observation method by first 
immobilizing actin filaments to the glass surface lightly coated with 
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poly-lysine and then applying a solution of cofilin-mCherry.  However, the 
poly-lysine treatment absorbed high concentration of cofilin-mCherry to the 
surface, which increased the background fluorescence and hindered the 
observation.  Further, since the binding of cofilin increases the twist of actin 
filaments (McGough et al., 1999), it is feared that immobilization of actin 
filaments might inhibit cofilin binding by restricting the twisting motion of 
the bound filaments.  It is therefore a challenge for the future improvement 
to design an experimental system that allows observation of binding of 
fluorescent human cofilin to actin filaments loosely immobilized on a surface. 
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Figure 3.  SDS-PAGE of cofilin-mCherry.  Lane 1 is the molecular weight 
markers.  Lanes 2 and 3 show two different batches of purified 
cofilin-mCherry.  The top bands in these lanes are cofilin-mCherry (deduced 
molecular weight = 48,598). 
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Figure 4.  Binding of cofilin-mCherry to actin filaments with bound ADP.  
Upper and lower images of each column are Alexa 488 and mCherry 
fluorescence micrographs of the same field, respectively.  In the presence of 
400 nM cofilin-mCherry, binding of cofilin-mCherry to actin filaments was 
barely detectable.  Some actin filaments were bound with cofilin-mCherry 
at 600 nM, and binding intensity increased when the concentration of 
cofilin-mCherry was further raised.  Alexa and mCherry fluorescence 
micrographs were taken and processed under the same condition, 
respectively, so that the fluorescence intensities can be compared within each 
row. Scale bar, 10 µm.  
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Figure 5.  Binding of cofilin-mCherry to actin filaments with bound ADP in 
the presence of 10 mM Pi.  Upper and lower images of each column are 
Alexa 488 and mCherry fluorescence micrographs of the same field, 
respectively.  Practically no binding of cofilin-mCherry to actin filaments 
was detected at all concentrations of cofilin-mCherry tested. Scale bar, 10 
µm. 
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Figure 6.  Binding of cofilin-mCherry to actin filaments incubated with 
AMP-PNP.  Upper and lower images of each column are Alexa 488 and 
mCherry fluorescence micrographs of the same field, respectively.  In the 
presence of 400 nM cofilin-mCherry, binding of cofilin-mCherry to actin 
filaments was barely detectable.  Some actin filaments were bound with 
cofilin-mCherry at 600 nM, and binding intensity increased when the 
concentration of cofilin-mCherry was further raised.  Alexa and mCherry 
fluorescence micrographs were taken and processed under the same 
condition, respectively, so that the fluorescence intensities can be compared 
within each row. Scale bar, 10 µm. 
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Figure 7.  Percentage of actin filaments with bound cofilin-mCherry.  For 
each determination, three sets of fluorescence micrographs were used, and a 
total of more than 300 filaments were evaluated.  Filaments with local 
binding were counted as bound, but small dot-like objects were not counted.  
In the case of filaments with bound ADP (a blue line with diamond symbols), 
fraction of bound filaments rose sharply between cofilin-mCherry 
concentration of 600 nM and 800 nM, and reached 90% at 800 nM.  A 
similar tendency was observed in the case of filaments incubated with 
AMP-PNP (a green line with triangle symbols), but the slope appeared 
shallower than in the case of ADP-bound filaments.  In the presence of 10 
mM Pi (a red line with square symbols), there were only 10 % of bound actin 
filaments even at 1,600 nM cofilin-mCherry.  This is in sharp contrast to the 
other two types of actin filaments. 
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Figure 8.  Two distinct intensities of cofilin-mCherry binding along actin 
filaments.  Shown here as an example is a set of fluorescence micrographs 
demonstrating binding of 600 nM cofilin-mCherry (middle) to ADP-bound 
Alexa 488-actin filaments (left).  The right is a merged image, with Alexa 
488 fluorescence shown in green and mCherry in red.  Actin filaments 
indicated by red arrows are not bound with cofilin-mCherry.  Those 
indicated by blue arrows have bound cofilin-mCherry at a moderate intensity. 
Those indicated by yellow arrows have much higher mCherry fluorescence 
than those indicated by blue arrows. Scale bar, 10 µm. 
  
24 
 
 
 
 
Chapter Ⅱ 
 
 
 
 
 
Characterization of Dominant Negative Asp11 Mutant 
Actins 
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INTORODUCTION 
 
A variety of mutant proteins have proven useful for elucidating the 
molecular mechanisms underlying protein functionality, and dominant 
negative mutants often provide unique opportunities in such studies.  In 
that regard, a large number of actin mutations, some of which are dominant 
negative, have been identified through experimental genetic screening (An 
and Mogami, 1996; Drummond et al., 1991; Noguchi et al., 2010a; Wertman 
et al., 1992) and analysis of human hereditary diseases (e.g., Laing et al., 
2009; Monserrat et al., 2007; Morita et al., 2008; Olson et al., 1998; van Wijk 
et al., 2003; Zhu et al., 2003).  Unfortunately, however, recombinant actin 
must be expressed in eukaryotic host cells (Sternlicht et al., 1993), and 
expression of dominant negative actin mutants is toxic to the cells, which has 
hampered the mutants’ biochemical characterization (Wertman et al., 1992).  
To overcome this limitation, Noguchi et al. (2007) developed a system for 
expressing toxic mutant actins in Dictyostelium.  With this system, 
thymosin  is fused to the C-terminal of the mutant actin to block its 
copolymerization with the endogenous actin.  The fusion protein is then 
purified and treated with chymotrypsin, which efficiently cleaves the protein 
immediately after the final native actin residue, separating the actin and 
thymosin moieties (Noguchi et al., 2007).  This expression system was used 
to characterize dominant negative actin mutations (Noguchi et al., 2010b) 
previously identified in Drosophila indirect flight muscle (An and Mogami, 
1996), as well as in a genetic screens using yeast cells (Noguchi et al., 2010a).  
These studies demonstrated the usefulness of dominant negative mutant 
actins and prompted me to characterize other dominant negative actin 
mutants. 
Within the budding yeast actin sequence, Asp 11 is a component of 
the nucleotide-binding site (Fig. 9) and is conserved among all known actins.  
The D11Q yeast actin mutant (D13Q in  actin and D12Q in the 
Dictyostelium actin 15; the yeast amino acid residue number will be used 
throughout this chapter) was found to bind DNase I only poorly (Solomon et 
al., 1988), and its overexpression in yeast cells demonstrated it to be 
dominantly lethal (Johannes and Gallwitz, 1991), making its purification for 
detailed biochemical characterization difficult.  More recently, a D11N 
mutation in human  actin was shown to dominantly cause congenital 
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myopathy (Laing et al., 2009), further highlighting the need to characterize 
Asp11 mutant actins in vitro.  I therefore constructed Dictyostelium 
versions of the D11N and D11Q mutant actins, purified them using the 
thymosin-fusion system, and characterized them in various biochemical 
assays.  The results demonstrate that D11N/Q actin polymers are abnormal 
in several ways: they are slow to polymerize to form filaments and are 
similarly slow to depolymerize, and their binding to cofilin is defective.  The 
monomeric forms also exhibit abnormalities, including defective cofilin 
binding and resistance to subtilisin cleavage at the DNase binding loop.  
Most notably, copolymers of D11N/Q and WT actins exhibit partial resistance 
to cofilin-mediated acceleration of depolymerization.  The failure of 
copolymerization with WT actin to fully correct the defective cofilin-induced 
depolymerization of D11N/Q actins suggests that defective cofilin binding is 
the primary reason why D11N/Q actins are dominantly toxic in yeast and 
human. 
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EXPERIMENTAL PROCEDURES 
 
Plasmid construction 
pTIKL ART (Noguchi et al., 2007) contains an ART gene, which is the 
Dictyostelium act15 gene modified to carry four unique restriction sites (the 
AR gene), followed by a Gly-based linker, a synthetic human thymosin  gene 
and a His tag.  pTIKL GFP-AR carries a GFP-fused AR gene (Noguchi et al., 
2007).  D11N and D11Q mutations were made using a PCR-based method, 
and the mutant genes were subcloned into pTIKL ART and pTIKL GFP-AR 
after confirmation by DNA sequencing.  The mutated sequences were 
GCTTTAGTTATTAATAACGGTTCTG and 
GCTTTAGTTATTCAAAACGGTTCTG for D11N and D11Q, respectively (the 
underlines show the mutated residues). 
 
Cell culture 
Dictyostelium discoideum Ax2 or KAX3 cells were transfected with 
pTIKL-based plasmids by electroporation (Egelhoff et al., 1991).  
Transfectants were then selected on plates at 21-22C in HL5 medium 
containing 60 µg/ml each of penicillin and streptomycin and 12 µg/ml G418.  
For biochemical purification of actin, KAX3 cells expressing either WT or 
mutant ART were grown on plates in medium containing 40 µg/ml G418; 
large-scale cultures were grown first in 25 x 25 cm2 plastic plates or 5 L 
conical flasks, and then in fresh HL5 medium containing 10 µg/ml G418 for 
an additional 24-36 h on a shaker. 
 
Observation of GFP-mutant actin in live Dictyostelium cells 
Ax2 cells expressing GFP-actin or its derivative were observed using 
a confocal laser scanning microscope (CSU-10, Yokogawa) (Noguchi et al., 
2007) 
 
Purification of actin and cofilin 
Recombinant WT and mutant actins were purified as described 
previously (Noguchi et al., 2010b).  Actin concentrations were estimated 
using an Advanced Protein Assay (Cytoskeleton, Denver, CO).  Actin 
calibrated based on absorption at 290 nm served as the standard. 
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Dictyostelium cofilin cDNA (Ddcof1) (Aizawa et al., 1995) was 
isolated from a cDNA library using the primers 
5'-GGTACCATGTCTTCAGGTATTGCT and 
5'-CAATTGGATTTTGGTACATTTTTCAT and, after sequence verification, 
was inserted at the BamHI and EcoRI sites of pCold I (Takara Bio, Otsu, 
Japan) or pCold I carrying a mCherry gene inserted at the EcoRI and XbaI 
sites.  These were used to express N-terminally His-tagged cofilin or 
cofilin-mCherry in E. coli Rosetta (DE3) cells.  The proteins were then 
purified using conventional methods. 
 
Polymerization assay 
Monomeric WT or mutant actin was diluted in G-buffer (2 mM Hepes 
(pH 7.4), 0.2 mM CaCl2, 0.1 mM ATP, 7 mM -mercapthoethanol, 0.05% 
NaN3) and incubated on ice for 10 min.  Polymerization was induced by 
addition of concentrated F-buffer, after which increases in 360 nm light 
scatter were monitored at 22C using a fluorescence spectrophotometer with 
a 100-µL cuvette.  The final concentration of each component was 5 µM 
actin, 2 mM Hepes (pH 7.4), 100 mM KCl, 2.5 mM MgCl2, 0.5 mM EGTA, 0.2 
mM ATP and 0.2 mM DTT. 
 
Depolymerization assays 
WT or mutant actin or a 1:1 mixture of WT and mutant actins were 
allowed to polymerize in F-buffer for 2 h at room temperature.  The total 
actin concentration was 5 µM.  Latrunculin A (Wako, Osaka, Japan) or 
DMSO control was then added to a final concentration of 60 µM or 0.3%.  
After incubation for 10 min, the mixtures were centrifuged at 250,000 x g for 
10 min at 20C, and the supernatant and pellet fractions were subjected to 
SDS-PAGE.  Alternatively, WT actin labeled with pyrene at Cys374 
(Kouyama and Mihashi, 1981) was used, and the reduction in pyrene 
fluorescence was monitored using a fluorescence spectrophotometer with 
excitation and emission wavelengths of 365 nm and 407 nm, respectively. 
For direct observation of the depolymerization of individual actin 
filaments, the filaments (10 µM) were labeled by incubation overnight on ice 
in buffer containing 200 µM Alexa-Fluor 488 succinimidyl ester (Invitrogen, 
Tokyo, Japan), 2 mM Hepes (pH 7.4), 50 mM KCl, 2.5 mM MgCl2, 0.5 mM 
EGTA and 0.2 mM ATP.  The reaction was stopped by addition of 0.1 M 
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Tris-Cl pH7.4.  After removing unbound dye using ion exchange resin 
(Dowex, 1x80, 100-200 Mesh), the labeled actin was dialyzed against 
G-buffer.  The labeled monomeric actin was then mixed with unlabeled WT 
or D11Q actin in G-buffer at a 1:1 ratio and polymerized in F-buffer for 2 h at 
room temperature, as above.  Once polymerized, the actin was diluted in 
assay buffer (10 mM Hepes (pH 7.4), 25 mM KCl, 4 mM MgCl2, 10 mM DTT 
and 0.5% bovine serum albumin) and introduced into flow cells coated with 
25 µg/mL skeletal heavy meromyosin, where it was incubated for 2 min.  
The flow cells were then perfused with copious amounts of 10 mM Hepes (pH 
7.4), 100 mM KCl, 2.5 mM MgCl2, 0.5 mM EGTA, 0.1 mM ADP, 10 mM DTT 
and an oxygen scavenger system, after which the actin filaments were 
observed using a fluorescence microscope (BX60, Olympus, Tokyo, Japan) 
equipped with an EB-CCD camera (C7190, Hamamatsu Photonics, 
Hamamatsu, Japan) at 25C. 
 
Phosphate Release Assay 
The time course of Pi release from polymerizing actin was measured 
by using an EnzChek phosphateassay kit (Invitrogen). Actin was 
polymerized at 10 µM, as described under “Polymerization Assay,” in the 
presence of 2-amino-6-mercapto-7-methylpurine riboside and 1 unit/ml 
purine nucleoside phosphorylase, and the absorbance at 360 nm was 
monitored. 
 
Stopped Flow Analyses 
The rates of 1,N6-ethenoadenosine 5 ε-triphosphate (ε-ATP) release 
from monomeric actin was measured at 25°C using a stopped flow system 
(SX18MV:Applied Photophysics, Leatherhead, UK). Actin filaments were 
dialyzed against G-buffer for 24 h, followed by second dialysis against 
G-buffer that contained 0.2 mM ε-ATP (Invitrogen) in place of ATP for 24 h 
(WT) or 48 h (mutants). This solution was rapidly mixed with an equal 
volume of G-buffer that contained 1 mM CaATP, and fluorescence excited by 
360 nm light and passed through a 395-nm cutoff filter was monitored. 
 
Cofilin-binding assay 
WT or mutant actin or a 1:1 mixture of WT and mutant actins were 
allowed to polymerize for 2 h at room temperature in buffer containing 20 
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mM Pipes (pH 6.5), 50 mM KCl, 2.5 mM MgCl2, 0.5 mM EGTA, 0.2 mM ATP 
and 0.2 mM DTT.  Cofilin was then added to a final concentration of 2.5 µM, 
and 5 min later the mixture was centrifuged at 250,000 x g for 10 min at 
20C.  The resultant supernatant and pellet fractions were subjected to 
SDS-PAGE. 
For microscopic observation of cofilin binding to actin filaments, 1 µM 
Alexa 488-labeled actin filaments were mixed with 2 µM cofilin-mCherry in 
buffer comprising 10 mM Pipes (pH 6.5), 50 mM KCl, 1 mM MgCl2, 5 mM 
DTT and 1 mM ATP.  After incubation for 1 min at 25C, the labeled actin 
filaments were diluted 10 fold in the same buffer, placed on a glass slide, 
overlaid with a coverslip, and observed using a fluorescence microscope. 
Cofilin binding to monomeric actin was detected by crosslinking the 
proteins using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC; Sigma, 
St. Louis, MO).  Mixtures of 7 µM actin and 14 µM cofilin in G-buffer were 
treated with 40 mM EDC for 5 min at 25C.  After stopping the reaction by 
addition of SDS sample buffer, the samples were analyzed by SDS-PAGE. 
 
Cofilin-induced depolymerization assay 
A 1:1 mixture of Alexa 488-labeled WT actin and unlabeled WT or 
D11Q actin was polymerized in F-buffer for 2 h at room temperature, as 
above.  The final concentration of each actin was 2.5 µM.  Hepes (pH 8.35) 
and cofilin were added to final concentrations of 10 mM and 10 µM, 
respectively, and 15 min later the mixture was centrifuged at 250,000 x g for 
10 min at 25C.  The supernatant and pellet fractions were then subjected 
to SDS-PAGE and stained with Coomassie Blue.  The gel was also viewed 
on a Molecular Dynamics Typhoon 8600 Imager (excitation wavelength: 532 
nm; GE Healthcare, Little Chalfont, UK). 
For microscopic observation of cofilin-induced 
severing/depolymerization of actin filaments, copolymers of Alexa 
488-labeled WT actin and either unlabeled WT or D11Q actin were diluted to 
40 nM in buffer containing 10 mM Hepes (pH 8.35), 30 mM KCl, 1 mM 
MgCl2, 0.2 mM ATP, 5 mM DTT and 2 µM cofilin.  After incubation for 5 min 
at 25C, the mixture was observed using a fluorescence microscope. 
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Subtilisin cleavage assay 
G-actin (5 µM) was digested with 1 µg/mL subtilisin (Sigma) at 25C 
in modified G-buffer (2 mM Tris-Cl (pH 7.4), 0.2 mM CaCl2, 0.2 mM ATP and 
0.1 mM DTT).  The reaction was then stopped by addition of 1 mM 
phenylmethylsulfonylfluoride, and the samples were analyzed by 
SDS-PAGE. 
 
DNase I inhibition assay 
DNase I activity was measured at 22C based on changes in A260 of 
G-buffer containing 50 µg/mL DNA (Sigma), 0.7 nM DNase I (Sigma) and 10 
nM G-actin. 
 
Electron microscopy 
WT or D11N/Q actin filaments in EM buffer (10 mM K-phosphate 
(pH 7.4), 25 mM KCl, 2.5 mM MgCl2, 0.2 mM ATP and 0.5 mM DTT) were 
placed on carbon-coated copper grids, stained with 1% uranyl acetate, and 
observed using an FEI Tecnai F20 electron microscope. 
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RESULTS 
 
Purification of D11N/Q actins 
D11N and D11Q mutant actins were successfully expressed and 
purified as thymosin  fusion proteins with a polyhistidine tag.  After 
separating the actin from the thymosin-his tag moieties through 
chymotryptic digestion, I was able to further purify the intact mutants using 
Q-Sepharose column chromatography followed by a cycle of polymerization, 
pelleting by ultracentrifugation, and dialysis against G-buffer. 
 
Polymerization of D11N and D11Q actins 
When monomeric D11Q actin in G-buffer was induced to polymerize 
by the addition of salts, the light scatter indicative of polymerization 
increased more slowly than with WT actin (Fig. 10A).  Nonetheless, D11Q 
actin filaments visualized by rhodamine-phalloidin staining appeared to be 
normal (Fig. 10B).  When a 1:1 mixture of WT and D11Q actins was allowed 
to polymerize, light scatter increased at an intermediate rate, between the 
rates for the WT and mutant homopolymers.  I, with the help of Dr. K. 
Hirose, next used electron microscopy to observe negatively stained D11N/Q 
actin under polymerizing conditions, and were surprised to find that most of 
the D11Q/N polymers formed either small rings or short rod-like structures 
without a noticeable double-helical appearance; there were few filaments 
with a normal appearance (Fig. 11C, E).  Addition of phalloidin did not 
noticeably increase the filamentous fraction of D11Q polymers (Fig. 11D).  
These results, together with the fact that the mutant actins were purified 
normally through a cycle of polymerization and depolymerization steps, 
indicate that D11N/Q actins are able to undergo salt-dependent reversible 
polymerization, but the polymerized products are mostly abnormal 
oligomeric structures. 
When a 1:1 mixture of D11Q actin labeled with Alexa 594 and WT 
actin labeled with Alexa 488 were induced to polymerize and then observed 
under a fluorescence microscope, the same filaments could be visualized 
using either fluorophore (Fig. 12A).  Interestingly, fluorescence intensities 
of both Alexa 488 and Alexa 594 were not homogeneous along the length of 
copolymers, suggesting the possibility that WT and D11Q actins tend to 
segregate from each other and form clusters.  In addition, very bright 
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fluorescent dots of Alexa 594 were observed along the length (Fig 12A, 
arrowheads).  This may represent oligomeric structures of D11Q actin 
associated along the sides of filaments, as seen in electron micrographs 
(arrowheads in Fig. 11C).  When GFP-fused D11Q actin was expressed in 
Dictyostelium cells, the fluorescence was localized along cell edges, in thin 
projections and in macropinocytotic cups (Fig. 12B).  This distribution was 
similar to that of GFP-WT actin (Fig. 12B), but distinctly differed from that 
of non-polymerizable GFP-WT actin fused at its C-terminal with thymosin  
(Fig. 12B).  The level of cytoplasmic GFP-D11Q actin fluorescence, which 
was derived from both monomeric and oligomeric GFP-actin, was low and 
comparable to that of GFP-WT actin, suggesting that GFP-D11Q and 
GFP-WT actins copolymerized with endogenous actin with similarly high 
efficiencies.  Western blotting analysis (Fig. 12C) showed that 53 ± 15% of 
GFP-WT actin was recovered in the Triton-insoluble fraction, whereas 30 ± 
2.3% of GFP-D11Q actin was in the insoluble fraction (N=3; the insoluble 
fraction of GFP-D11Q actin fused with thymosin  was 7.0 ± 0.8%). 
 
Depolymerization of D11N/Q actins 
I next used three different methods to analyze the depolymerization 
of D11N/Q polymers.  In the first experiment, depolymerization was 
induced by addition of latrunculin A, which sequestered monomeric actin 
from the solution.  After treatment for 10 min, the polymeric and 
depolymerized fractions were separated using ultracentrifugation and 
visualized using SDS-PAGE (Fig. 13A, B).  After the latrunculin treatment, 
most of the WT actin was recovered in the supernatant fraction, whereas a 
majority of the D11N/Q actin was pelleted.  Intriguingly, 1:1 WT-D11Q 
copolymers were also more resistant to latrunculin treatment than were WT 
homopolymers.  In the second experiment, I copolymerized pyrenyl WT 
actin and D11Q actin; then following addition of latrunculin A, I monitored 
the reduction in pyrene fluorescence as an indicator of depolymerization of 
WT subunits within the copolymers (Fig. 13C).  This experiment revealed 
that WT subunits copolymerized with D11Q actin were significantly slower 
to depolymerize than were WT homopolymer filaments. 
The results summarized above suggest that not only are 
Asp11-mutant actins slow to depolymerize, they also slow the 
depolymerization of copolymerized WT actin.  However, I was unable to rule 
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out the possibility that D11N/Q actins did not bind lactruculin A, or that the 
fluorescent signal observed in Figure 13B was derived from pyrenyl WT 
actin trapped within the rings or rod-like structures.  Therefore, in the third 
experiment, copolymers of Alexa 488-labeled WT actin and unlabeled WT or 
D11Q actin were immobilized on glass surfaces coated with skeletal muscle 
heavy meromyosin; then after washing out the free monomeric actin, the 
depolymerization of individual filaments was followed by observation using 
fluorescence microscopy (Fig. 13D).  Filaments often fragmented, 
presumably due to the strong excitation light, and very short fragments 
diffused away because the density of the heavy meromyosin molecules on the 
surface was low.  I identified fragmentation events based on sequential 
images taken at 5-min intervals, and analyzed changes in the lengths of 
unfragmented filaments.  WT homopolymer filaments shortened at a rate of 
0.16 ± 0.083 µm/min (average ± SD, N=55), which is roughly consistent with 
the estimate for skeletal Mg-actin (0.1 µm/s) under slightly different buffer 
conditions (Fujiwara et al., 2002).  By contrast, Alexa 488-WT/D11Q 
copolymer shortened at about half that rate (0.072 ± 0.049 µm/min; N=56).  
This finding qualitatively confirms the results of the latrunculin 
experiments and demonstrates that copolymerization with D11Q actin slows 
the depolymerization of WT actin within filaments. 
 
Effect of Asp-11 Mutations on Nucleotide Exchange and Phosphate Release 
Rates 
 The strategic position of Asp-11 in the nucleotide binding pocket and 
the aberrant polymerization/ depolymerization properties of the 
Asp-11-mutant actins suggested that those mutant actins have altered 
nucleotide binding properties.  Thus, I together with Dr. K. Ito of Chiba 
University first examined the release rates of bound nucleotides by 
measuring the decrease in the fluorescence of ε-ATP when bound ε-ATP was 
released in the presence of excess ATP (Fig. 14A).  ε-ATP that was bound to 
WT actin was released at a rate of 0.012 ± 0.0029 s-1, which is consistent with 
previous measurements using skeletal actin (Kudryashov et al., 2010; Miller 
and Trybus, 2008). In contrast, ε-ATP bound to monomeric D11Q actin was 
released at an ~40-fold faster rate of 0.42 ± 0.098 s-1. Release from D11N 
actin was even 10-fold faster, at 4.0 ± 0.16 s-1.  I have not directly measured 
the affinities of WT or mutant actins for ATP, but the extremely rapid 
35 
 
dissociation of ε-ATP from the mutant actins suggested much lower affinity 
of monomeric mutant actins, especially of D11N actin, for ATP.  This 
speculation and the fact that purified D11N actin loses competence to 
polymerize normal filaments (Fig. 10), as well as large batch-to batch 
variations among different D11N preparations (data not shown), suggested 
that D11N actin quickly denatured during and/or after dialysis against 
G-buffer containing 0.1 mM ATP.  This precluded D11N actin from further 
quantitative biochemical characterizations, and Dr. Uyeda focused his 
subsequent analyses on D11Q actin. 
I next compared the rates of nucleotide release from WT and D11Q 
filaments (Fig. 14B).  Consistent with previous measurements that 
nucleotide release is very slow from skeletal actin filaments (Kitagawa et al., 
1968; Martonosi et al., 1960; Strohman, 1959), the increase in fluorescence of 
ε-ATP was very small and slow, if at all, when phalloidin-stabilized WT 
filaments that were dialyzed against F-buffer containing 0.1mM ATP and 
then treated with the Dowex resin to remove free ATP were mixed with 0.1 
mM ε-ATP.  In contrast, a large increase in fluorescence intensity was 
observed with D11Q filaments over the 3-h time course.  The time course 
did not fit a single exponential curve well, suggesting the presence of two or 
more different populations of D11Q subunits, such as the ATP-bound and 
ADP-bound forms or the normal filaments and oligomeric structures.  In 
any case, it was clearly demonstrated that D11Q actin subunits in filaments 
release bound nucleotides much more rapidly than the WT subunits in 
filaments and rebind ATP. 
A nearly stoichiometric amount of phosphate was released from 
polymerizing WT actin with a relatively short lag following an increase in 
light scattering (Fig. 10A).  Phosphate was released from polymerizing 
D11Q actin as well, although the lag between polymerization and phosphate 
release was significantly larger with D11Q actin, suggesting either slower 
ATP hydrolysis or higher affinity for Pi after hydrolysis on D11Q actin 
subunits in filaments.  Nonetheless, despite the rapid release of bound ATP, 
D11Q actin clearly retains the activity to hydrolyze ATP in a 
polymerization-dependent manner. 
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Effect of Asp11 mutation on cofilin binding and severing by cofilin 
Cofilin is the major actin depolymerizing factor in vivo (Bernstein 
and Bamburg, 2010; Carlier, 1998), with activities to sever filaments 
(Maciver et al., 1991), depolymerize actin filaments (Mabuchi, 1981; Nishida 
et al., 1984), possibly by enhancing subunit dissociation from pointed ends of 
the filaments (Carlier et al., 1997), and bind to actin monomers (Mabuchi, 
1981; Nishida et al., 1984).  Thus, the effects of D11Q mutation on 
interactions with cofilin were next examined. 
Cosedimentation of cofilin with actin polymers at pH 6.5, a condition 
under which cofilin binds to actin filaments without significantly 
depolymerizing them (Hawkins et al., 1993; Pavlov et al., 2006; Yonezawa et 
al., 1985), showed that, although WT filaments and copolymers of WT and 
D11Q actins bound cofilin with similar affinities, D11Q homopolymers 
hardly bound cofilin (Fig. 15A).  However, it was not possible to determine 
unequivocally that D11Q subunits within normal homopolymer filaments 
bound cofilin, because unknown fractions of the mutant actin molecules were 
sequestered in oligomeric structures.  Thus, mCherry-fused cofilin was 
added to Alexa-Fluor 488-labeled D11Q or WT filaments, and found under a 
fluorescence microscope that cofilin-mCherry hardly bound the D11Q 
filaments, although it bound and disassembled WT filaments (Fig. 15B). 
Binding of cofilin to monomeric D11Q actin was next assayed by 
cross-linking in G-buffer.  Although G-buffer has a very low concentration of 
salts and would enhance actin-cofilin binding more than under physiological 
conditions, monomeric D11Q actin was cross-linked to cofilin at a 
significantly slower rate than WT actin (Fig. 15C).  Taken together, it was 
concluded that D11Q actin has lower affinities for cofilin in both filamentous 
and monomeric forms, as well as in the small oligomeric structures. 
Next, the activities of cofilin against D11Q actin were assayed at 
pH8.3, the condition under which cofilin efficiently depolymerizes actin 
filaments (Hawkins et al., 1993; Pavlov et al., 2006; Yonezawa et al., 1985), 
using two different assays.  In the first set of experiments, cofilin-induced 
depolymerization was assayed by ultracentrifugation followed by SDS-PAGE.  
Incubation with 10 µM cofilin for 15 min released more than half of the 
subunits to the supernatant fraction from the WT filaments.  In contrast, 
copolymer filaments of Alexa-Fluor 488-WT actin and unlabeled D11Q actin 
were significantly resistant to depolymerization by cofilin (Fig. 16A).  
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Observation of gel fluorescence demonstrated that Alexa-Fluor-labeled WT 
actin was also protected from cofilin activity when copolymerized with D11Q 
actin (Fig. 16A).  Densitometric scanning of the gels showed that 
cofilin-induced depolymerization of Alexa- Fluor 488-WT actin in copolymers 
with D11Q actin was 38 ± 9% (n = 3) of that in homopolymers. 
In the second set of experiments, fluorescence microscopy was used to 
monitor the disappearance of WT homopolymer and WT/D11Q copolymer 
filaments.  When 40 nM Alexa-Fluor 488-WT actin filaments were 
incubated with 2 µM cofilin, filaments disappeared almost completely within 
6 min (Fig. 16B).  In contrast, many filaments remained when 40 nM 1:1 
copolymer filaments of Alexa-Fluor 488-WT and unlabeled D11Q actins were 
treated with 2 µM cofilin for 6 min.  Some filaments remained even after 26 
min (data not shown), further indicating that copolymer filaments of WT and 
D11Q actins were significantly resistant to the depolymerizing activity of 
cofilin. 
Strikingly, when I performed cofilin-depolymerization assay in 
F-buffer that contained 1 mM ADP in addition to 0.1 mM ATP, cofilin was 
able to depolymerize D11Q filaments fairly efficiently, although not as 
efficiently as WT actin in the presence of ADP (Fig. 17).  This result 
suggested that ADP in the buffer was incorporated into D11Q subunits in 
the filaments, due to the very rapid exchange of bound nucleotides, and 
made them susceptible to cofilin activity, whereas in the standard F-buffer 
that only contained ATP, most of the D11Q subunits carried bound ATP even 
if bound ATP was hydrolyzed to ADP, which conferred resistance to cofilin 
activity.  Under a more physiological condition, i.e. in the presence of 1 mM 
ATP and 50 µM ADP (Williams et al., 1993), D11Q actin was resistant to 
cofilin activity, suggesting that D11Q actin subunits were resistant to cofilin 
activity in vivo. 
 
Allosteric effect of Asp11 mutation on the structure of DNase loop 
Finally, effects of Asp11 mutation on the structure of the DNase loop 
were examined.  First, the structure of the DNase loop was monitored based 
on its susceptibility to cleavage by subtilisin (Muhlrad et al., 2004).  
SDS-PAGE analysis showed that in the presence of 1 µg/mL subtilisin, WT 
G-actin was cleaved almost completely within 5 min under our experimental 
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conditions.  By contrast, D11Q G-actin was cleaved at a much slower rate 
under the same conditions (Fig.18A). 
The DNase loop is involved in actin binding to DNase I and inhibiting 
the enzyme’s activity (Kabsch et al., 1990; Lazarides and Lindberg, 1974).  
Again, D11Q actin bound to and inhibited DNase I much less efficiently than 
WT actin (Fig. 18B).  Given that DNase I binds to monomeric actin, this 
finding, as well as the results of the subtilisin cleavage (Fig. 18A) and cofilin 
crosslinking (Fig. 15) experiments, suggest that the structure of the 
monomeric Asp11-mutant actin also significantly differs from the WT 
structure. 
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DISCUSSION 
 
The Asp11 mutation has been shown to be dominantly negative both 
in yeast actin (Johannes and Gallwitz, 1991) and human α actin, the latter 
leading to congenital myopathy (Laing et al., 2009).  In vitro 
characterizations reported here revealed that both D11N and D11Q mutant 
actins undergo salt-dependent reversible polymerization, and the resultant 
filaments appear normal when observed by low resolution electron 
microscopy.  However, relatively few normal filaments were formed with 
purified D11N actin, presumably due to denaturation during overnight 
dialysis against G-buffer containing 0.1 mM ATP, which forced us to focus 
our detailed biochemical analyses on D11Q actin. 
D11Q filaments move more or less normally on surfaces coated with 
skeletal heavy meromyosin (data not shown), and interaction of monomeric 
D11Q with profilin and thymosin  appeared normal as well in the context of 
fusion proteins in vivo (T. Uyeda, unpublished data).  Nonetheless, D11Q 
actin showed a number of biochemical defects.  For instance, D11Q actin 
filaments depolymerized more slowly than WT filaments, as did copolymer 
filaments of WT and D11Q actins (Fig. 13).  Furthermore, both monomer 
and filament forms of D11Q rapidly exchanged bound nucleotides with free 
nucleotides in solution (Fig. 14), and failed to interact properly with cofilin 
(Figs. 15-18).  ADP concentration is much lower than ATP in cells (Williams 
et al., 1993) as well as in standard G- and F-buffers, so that the rapid 
exchange of bound nucleotides would allow most of the D11Q actin molecules 
to carry ATP, even if the hydrolysis activity is normal, both in vivo and in 
vitro.  ATP-bound skeletal actin is slower to depolymerize than ADP-bound 
actin (reviewed by (Korn et al., 1987)), and this may be at least one of the 
reasons why D11Q actin filaments are slower to depolymerize.  In 
copolymer filaments of D11Q and WT, slow dissociation of ATP-bound D11Q 
subunits from depolymerizing ends would cause pauses, leading to slower 
average depolymerization rates of copolymers.  Although my analyses on 
D11N actin were limited, I believe the same explanation is applicable to 
D11N actin since D11N actin monomers released bound nucleotides even 
more rapidly. 
In cells, however, spontaneous depolymerization of actin filaments is 
unlikely to play any important roles, as the concentration of monomeric actin 
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is above the critical concentration for polymerization, and it is generally 
believed that cofilin-mediated depolymerization from the pointed ends of 
filaments is physiologically relevant (Carlier et al., 1997).  D11Q actin 
monomers and homopolymers do not bind cofilin (Figs. 14 and 15), and 
render copolymer filaments with WT actin partially resistant to the 
depolymerizing activity of cofilin (Fig. 16).  Considering very rapid turnover 
of actin subunits in dynamic structures within non-muscle cells (Murthy and 
Wadsworth, 2005; Theriot and Mitchison, 1991; Theriot et al., 1992), this 
slow depolymerization of copolymer filaments of WT and D11Q mutant 
actins may well be deleterious for non-muscle cells, including yeast.  Again, 
the rapid exchange of bound nucleotides would explain why D11Q filaments 
do not bind cofilin, since the cellular concentration of ATP is much higher 
than that of ADP (Williams et al., 1993), and cofilin is unable to bind 
ATP-bound actin filaments (Carlier et al., 1997).  This view is consistent 
with the fact that D11Q filaments were efficiently depolymerized by cofilin in 
F-buffer containing 1 mM ADP in place of ATP (Fig. 18). 
The inability of monomeric D11Q actin molecules to bind cofilin 
would cause additional problems.  The cellular concentration of total actin 
is well above the critical concentration for polymerization, and a number of 
actin-binding proteins are present to maintain a polymerization-competent 
monomeric actin pool.  Although there is evidence against the simple idea 
that cofilin sequesters monomeric ADP-actin from polymerization (Blanchoin 
and Pollard, 1998), differential high affinity of cofilin for ADP-actin 
monomer over ATP-actin monomer (Carlier et al., 1997; Maciver and Weeds, 
1994) suggests a role of cofilin in this complex process, which would not work 
with Asp11 mutant actins in the cells. 
In light of the traditional notion that the turnover of sarcomeric actin 
is only slow in muscle cells (Zak et al., 1977), it is not intuitively obvious if 
the same cofilin-related explanations are applicable to the dominant 
negative effect of D11N mutation in the α actin gene leading to myopathy.  
However, it is now established that actin subunits turnover rapidly in both 
developing and mature muscle cells (reviewed by Ono, (2010)).  
Furthermore, cofilin is expressed in muscle cells (Nakashima et al., 2005), 
and recent studies provided evidence that mutation in cofilin causes 
nameline myopathy (Agrawal et al., 2007), and that cofilin is required for 
muscle development (Agrawal et al., 2012) and maintenance 
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(Miyauchi-Nomura et al., 2012).  In the mutant muscle cells, D11N actin is 
probably present at the same concentration as WT.  This would lead to a 
modest retardation of cofilin-mediated depolymerization of copolymer actin 
filaments and disturb the turnover of actin monomer, so that the mutant 
muscle cells become sick, but do not die.  Dictyostelium cells expressing 
GFP-D11Q actin did not show noticeable defects in growth or cell 
morphology (data not shown).  This is presumably because the relative 
content of GFP-D11Q actin was much less than that of endogenous actin, as 
was the case with other GFP-mutant actins (Noguchi et al., 2010b). 
G146V is another dominant lethal actin mutation in yeast, which 
also inhibits cofilin binding (Noguchi et al., 2010a).  The K336I mutation, 
which in human α actin causes congenital myopathy (Laing et al., 2009), also 
makes Dictyostelium actin incapable of binding cofilin (N. Umeki and T. 
Uyeda, unpublished data).  Furthermore, the P332A mutation in γ actin, 
which causes autosomal dominant nonsyndromic progressive deafness, was 
resistant to depolymerization by cofilin (Bryan and Rubenstein, 2009).  
Taken together, I propose that a significant fraction of 
polymerization-competent dominant negative mutant actins exert toxic 
effects by dominantly disturbing cofilin-mediated dynamic regulation of the 
actin cytoskeleton.  It was recently found that N12D mutation in the  actin 
gene causes Baraitser-Winter syndrome (Riviere et al., 2012), and it will be 
interesting to investigate if this mutation, which occurred right next to 
D11N in the opposite direction, increases or decreases the sensitivity to the 
cofilin activity. 
A recent high resolution structural study demonstrated that the side 
chain of Asp11 indirectly interacts with the β phosphate of ADP through a 
water molecule (Murakami et al., 2010).  It thus makes sense that mutating 
Asp11 changes the affinity for nucleotides, although it is not intuitively 
obvious why changing to Asn causes a more severe phenotype than to Gln.  I 
speculate that this modification of nucleotide binding affinity can explain 
much of the defective interaction of D11Q actin with cofilin.  However, 
cofilin was unable to depolymerize D11Q actin filaments as efficiently as WT 
filaments even in the presence of 1 mM ADP.  This may be due to slower 
ATP hydrolysis or Pi release from D11Q actin in filaments.  Furthermore, 
the slower polymerization of Asp11 mutant actins is difficult to explain by 
rapid nucleotide exchange, together suggesting additional mechanisms by 
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which Asp11 mutations affect the interaction with cofilin and/or impair 
cellular function of the mutant actin.  Mutation to Asp11 may allosterically 
affect the conformation of subdomain 2, as allosteric interactions between 
subdomain 2 and the nucleotide binding cleft (Combeau and Carlier, 1988; 
Muhlrad et al., 1994), including those involving cofilin (Muhlrad et al., 
2006),have been reported.   Thus, this allosteric effect of Asp11 mutations 
may impair the interaction with cofilin and other actin subunits during 
polymerization, since subdomain 2 of actin is a major binding site for cofilin 
(Galkin et al., 2001; McGough et al., 1997) as well as for the adjacent actin 
subunit on the pointed side within the same protofilament (Fujii et al., 2010; 
Holmes et al., 1990; Murakami et al., 2010; Oda et al., 2009).  Detailed 
structural analyses of Asp11-mutant actins should shed light on these 
biologically important intramolecular communications. 
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Figure 9.  Conserved Asp11 shown in a space filling representation within 
the atomic structure of an actin filament (PDB ID: 3G37) (Murakami, et al.,  
2010 ).  The DNase loop is modeled as a helix and is darkly colored at the 
upper right corner in this structure.  Shown in a ball and stick 
representation is the bound ADP.  Numbers show the subdomains. 
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Figure 10.  Polymerization of WT and Asp11 mutant actins.  A: 
Polymerization of WT (filled circles), D11Q (filled triangles), and D11N (filled 
squares) actin solutions.  Final concentration of actin was 10 µM, and 
polymerization was monitored by the increase of light scattering at 360 nm 
(left abscissa).  In parallel, release of phosphate from polymerizing WT 
(open circles) and D11Q (open triangles) actin was monitored using the 
EnzCheck phosphate assay kit (right abscissa).  Arrow indicates light 
scattering of D11N actin polymer at 160 min.  B: Fluorescence micrograph 
of WT, D11Q, and D11N actin filaments stained by rhodamine-phalloidin 
overnight at 5°C.  For D11N actin, the partially purified fraction from 
Q-Sepharose column chromatography and the purified fraction by a 
depolymerization/polymerization cycle are shown.  Bar: 10 µm.  AU: 
arbitrary units. 
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Figure 11.  Electron micrographs of negatively stained actin polymers.  WT 
(A, B), D11Q (C, D) and D11N (E, F) actins were polymerized in F-buffer in 
the absence (A, C, E, F) or presence (B, D) of 20 µM phalloidin for 2 h, diluted 
and stained with uranyl acetate.  Arrowheads indicate oligomeric 
structures in D11Q polymers that are associated along the length of 
filaments.  F is an enlarged image of the boxed area in (E).  Bars are 50 nm, 
except for F (25 nm). 
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Figure 12.  Copolymerization of WT and D11Q actin.  A: Filaments 
obtainedby copolymerization of WTactin labeled with Alexa-Fluor 488 and 
D11Q actin labeled with Alexa-Fluor 594.  The two fluorophores were 
observed in the green (left) and red fluorescence (right) channels, 
respectively.  Arrowheads indicate puncta of Alexa-Fluor 594-D11Q actin 
within or along copolymers.  Bar: 20 µm.  B: Fluorescence micrograph of 
Dictyostelium cells expressing GFP-WT actin, GFP-D11Q actin, and 
GFP-WT actin fused with thymosin .  Arrows indicate the accumulation of 
GFP-actin along cell peripheries and thin projections, and arrowheads 
indicate enrichment around macropinocytic cups.  Bar: 20 µm.  C : Western 
blotting analysis of cells expressing GFP-WT actin, GFP-D11Q actin, or 
GFP-D11Q actin fused with thymosin .  Triton-soluble (S) and -insoluble 
(P) fractions were separated by SDS-PAGE and probed with anti-GFP 
antibodies.  
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Figure 13.  Depolymerization of D11N/Q actins.  A, B: Latrunculin-induced 
depolymerization of D11Q and D11N actins.  Solutions of polymers of WT or 
mutant actin or a 1:1 mixture of the two were ultracentrifuged with or 
without preincubation for 10 min with 60 µM latrunculin A.  The 
supernatant and pellet fractions were analyzed by SDS-PAGE, and the 
fractions in pellets were determined using densitometry.  Error bars 
indicate the standard deviation of three independent measurements.  C: 
Latrunculin-induced depolymerization of pyrenyl WT actin copolymerized 
with the same concentration of unlabeled WT (filled circles) or D11Q (open 
circles) actin and assayed as in A.  D: Depolymerization of individual actin 
filaments.  Alexa 488-labeled WT actin copolymerized with the same 
concentration of unlabeled WT or D11Q actin was immobilized on heavy 
meromyosin-coated surfaces and imaged immediately and 10 min after 
flushing with buffer without actin.  Bar: 20 µm. 
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Figure 14.  Nucleotide release from WT and Asp11 mutant actins.  A: 
Release of ε-ATP from monomeric actin was assayed using a stopped flow 
apparatus.  An actin solution dialyzed against G-buffer containing 0.2 mM 
ε-ATP was rapidly mixed with an equal volume of G-buffer containing 1 mM 
Ca-ATP.  The averages of 3, 7 and 7 traces of WT, D11Q and D11N actins, 
respectively are shown, and the fine solid line shows fitting with 
single-exponentials.  B: Exchange of filament-bound ATP with exogenous 
ε-ATP, as assayed by an increase in fluorescence following the addition of 0.1 
mM ε-ATP to solutions of WT (circles) or D11Q (triangles) actin filaments 
dialyzed against F-buffer containing 0.1 mM ATP and then treated with 
Dowex resin to remove free ATP.  Solid lines show fitting with single (WT) 
and double (D11Q) exponentials. 
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Figure 15.  Cofilin binding.  A: Cosedimentation of 5 µM WT, D11Q and 1:1 
mixture polymers with 2.5 µM cofilin at pH 6.5.  Supernatant and pellet 
fractions after ultracentrifugation were analyzed by SDS-PAGE.  
Densitometric analyses of three sets of data showed that 49.5 ± 4.7%, 0.57 ± 
0.09% and 42.8 ± 2.1% of cofilin cosedimented with WT, D11Q and WT+D11Q 
filaments, respectively.   B: Fluorescence microscopic observation of binding 
of cofilin-mCherry to WT or D11Q actin filaments labeled with Alexa Fluor 
488.  Bar: 15 µm.  C: Cofilin binding to monomeric actin.  Binding of 14 
µM cofilin to 7 µM monomeric WT or D11Q actin in G-buffer, detected by 
crosslinking with 40 mM EDC for 5 min, followed by SDS-PAGE.  Arrow 
shows the position of the crosslinked actin-cofilin.  Average of three 
independent measurements indicated that the crosslinking of D11Q actin 
was 47% ± 15% slower than WT actin, and this difference is statistically 
significant with p<0.16 by Student's t-test.  Higher molecular weight 
ladders formed in D11Q-cofilin cross-link reactions were formed even when 
D11N or D11Q actin, but not WT actin, was treated with 
1-ethyl-3-(3-dimethylaminopropyl) carbodiimide in G-buffer in the absence of 
cofilin. 
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Figure 16.  Cofilin-induced depolymerization.  A: 5 µM WT actin filaments 
and a 1:1 mixture of WT and D11Q actin polymers were treated with 10 µM 
cofilin at pH 8.3, and after incubation for 15 min, the mixtures were 
subjected to ultracentrifugation followed by SDS-PAGE of the supernatant 
and pellet fractions.  2.5 µM WT actin was labeled with Alexa Fluor 488.  
Fluorogram visualized WT subunits only and Coomassie stained both WT 
and mutant actins.  B: Fluorescence microscopic observation of 
cofilin-induced depolymerization of Alexa Fluor 488-labaled WT filaments 
and 1:1 copolymer of labeled WT and unlabeled D11Q actin.  Bar: 20 µm 
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Figure 17.  Effects of ADP on cofilin-mediated depolymerization of actin 
filaments.  WT or D11Q actin filaments in F-buffer containing 0.1 mM ATP 
were diluted to 5 µM in F-buffer that contained 2 mM Hepes pH 7.4 and 
various concentrations of nucleotides.  After 30 min of incubation, 
concentrated Hepes buffer pH 8.35 and cofilin were added to a final 
concentration of 10 mM and 10 µM, respectively.  After incubation for 15 
min, the mixtures were subjected to ultracentrifugation and supernatant 
and pellet fractions were analyzed by SDS-PAGE.  A is a representative of 
three independent sets experiments.  B shows the average and standard 
deviation of the three sets of data.  The difference between cofilin-induced 
depolymerizatio of WT actin and D11Q actin in the presence of 1 mM ATP, as 
well as that of D11Q actin between 1 mM ATP and 1 mM ADP, were 
statistically significant by Student's t-test (p<0.001). 
  
52 
 
 
Figure 18.  Effects of D11Q mutation on the conformation of the DNase loop 
in monomeric actin.  Time course of the subtilisin cleavage of monomeric 
WT and D11Q actins in G-buffer, as assayed by SDS-PAGE and densitometry 
of the stained gel.  Inset: SDS-PAGE of WT and D11Q actins at 0 (control) 
and 2.5 min (+sub) of incubation with 1 µg/mL subtilisin.  B: Inhibitory 
effect of WT and D11Q actins on the activity of DNase I.  Student's t-test on 
three independent sets of data indicated that the difference is significant 
with p=0.016. 
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General Discussion 
 
  
54 
 
Interactions between actin and cofilin play critical roles in regulating 
the cytoskeletal reorganizations, and this study was carried out to 
understand the molecular mechanisms behind those processes, with a 
special emphasis on the differences in actin-bound nucleotides. 
 
In Chapter I entitled “Effects of bound nucleotide on the affinity of 
actin for cofilin”, I was able to observe cooperative binding of human cofilin 
to actin filaments using fluorescence microscopy.  Cooperative binding of 
cofilin to actin filaments, and cooperative conformational changes of actin 
filaments that accompany the cooperative binding, have been observed using 
electron microscopy (Galkin et al., 2001; McGough et al., 1997).  If the 
cooperative structural changes of actin filaments play roles in the 
cooperative binding of cofilin to actin filaments in the cells, it would be 
necessary to observe cooperative binding of cofilin to actin filaments with an 
observation field of the scale of cells, i.e., in the range of micrometers.  
Fields of view of electron microscopes are too narrow for this purpose, and 
the present study, which used fluorescence microscopy, demonstrated that 
cooperative binding occurs in the length scale of micrometers along actin 
filaments.  Suarez et al. independently reached the same conclusion (Suarez 
et al., 2011). 
Theoretically, cooperative binding of cofilin to actin filaments could 
occur through two different mechanisms.  In one model, affinity between 
cofilin molecules could drive formation of clusters, i.e., cooperative binding, 
along actin filaments.  However, recent high resolution electron microscopic 
structural analysis showed that cofilin molecules in clusters along actin 
filaments do not directly contact the neighbor molecules (Galkin et al., 2011), 
ruling out this possibility.  The second model assumes that cofilin binding 
induces a specific conformational change in bound actin subunits, and this 
conformational change is propagated to neighbor actin subunits, which in 
turn increases the affinity of that neighbor subunit for a new cofilin molecule.  
Because binding of cofilin causes major structural changes in bound actin 
subunits, including supertwisting of the helix by 25% (Galkin et al., 2001; 
McGough et al., 1997), it is reasonable to speculate that the supertwisted 
conformation of actin filaments in cofilin clusters is propagated to neighbor 
actin subunits and attracts more cofilin binding.  Until very recently, this 
second model has been hypothetical, but Ngo, Kodera and their colleagues 
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recently demonstrated by high speed atomic force microscopy that the 
supertwisted conformation is actually propagated to neighbor actin subunits, 
and more cofilin molecules bind to the newly supertwisted segment of the 
filament (Ngo et al., manuscript in preparation).  Other actin-binding 
proteins, including the motor domain of myosin II (Orlova and Egelman, 
1997; Tokuraku et al., 2009), drebrin (Sharma et al., 2012), -catenin 
(Hansen et al., 2013), fimbrin (Volkmann et al., 2001), and tropomyosin 
(Butters et al., 1993) have been shown to bind actin filaments cooperatively, 
and those cooperative bindings may also depend on cooperative structural 
changes of actin filaments.  In particular, binding of myosin II motor 
domain was shown to change the structure of actin filaments, including 
untwisting of the helical pitch (Tsaturyan et al., 2005).  It is notable that 
this untwisting conformational change of actin filaments induced by myosin 
II is completely different from the supertwisting structural changes induced 
by cofilin.  Thus, Uyeda et al. (2011) speculated that cofilin cannot bind to 
actin filaments to which myosin II is already bound cooperatively, and 
conversely, myosin II cannot bind to actin filaments to which cofilin is 
already bound cooperatively.  This hypothesis can be generalized that 
cooperative conformational changes of an actin filament play important roles 
in selecting the actin-binding protein, and hence, specifying the function of 
the actin filament (Galkin et al., 2012; Michelot and Drubin, 2011; 
Romet-Lemonne and Jegou, 2013; Schoenenberger et al., 2011; Tokuraku et 
al., 2009; Uyeda et al., 2011).  I anticipate that the results of the present 
study, which demonstrated cooperative binding of cofilin in the micrometer 
range, would provide useful framework to elucidate the control mechanism of 
the actin cytoskeleton. 
In addition, I demonstrated that human cofilin efficiently binds actin 
filaments carrying ADP in a cooperative manner, but almost not at all to 
those carrying ADP and Pi.  This result is consistent with the 
aforementioned fluorescence microscopic analyses of yeast cofilin (Suarez et 
al., 2011) as well as classic biochemical analyses (Blanchoin and Pollard, 
1999; Carlier et al., 1997).  As I have discussed in Chapter I, actin 
monomers in the cells carry bound ATP.  When incorporated into a filament 
from the barbed-end, hydrolysis of ATP is stimulated (Murakami et al., 2010) 
and eventually Pi is released.  Thus, actin subunit with bound ATP is 
restricted to the barbed-end of the filament, while the ADP-bound form 
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accumulates near the pointed end (reviewed by Carlier, (1990)).  
Consequently, the property of cofilin to bind cooperatively to actin subunits 
carrying ADP would bias cofilin binding to, and severing of, the older parts of 
the actin filaments, and this may be physiological important for proper 
reconstruction of the actin cytoskeleton. 
 
In Chapter II entitled “Characterization of Dominant Negative 
Asp11 Mutant Actins”, with the help of colleagues in the laboratory, I 
analyzed biochemical properties of the D11Q mutant actin that was shown 
by a previous yeast study to be dominant lethal (Johannes and Gallwitz, 
1991), and a similar D11N mutation in -actin that causes congenital 
myopathy in human (Laing et al., 2009).  I showed that, these mutant 
actins exchange bound nucleotides very quickly, even when in filaments, 
with that in external solution.  In cells, ATP concentration is much higher 
than that of ADP, and therefore, this property of the Asp11 mutant actins 
would render the majority of molecules ATP-bound.  Because cofilin binds 
preferentially to actin subunits carrying ADP as described above, these 
Aps11 mutant actins become resistant to the binding of and severing by 
cofilin.  Interestingly, co-filaments of wild-type and D11Q mutant actins 
were also less susceptible to the severing action of cofilin.  This is probably 
related to the requirement of cooperative conformational changes of actin 
filaments for cofilin binding, assuming that the Asp11 mutant actin 
molecules in co-polymers interfere with the cooperative conformational 
changes.  This last property of the Asp11 mutant actins is presumably the 
reason why the mutant actins are not only non-functional but also 
dominantly toxic, in a sense that the protein is harmful to the cells even in 
the presence of wild type molecules.  In conclusion, this study demonstrated 
the critical importance of very slow nucleotide exchange at actin subunits 
within filaments.   
 
It will be interesting in the future to unveil the detailed molecular 
mechanism of cofilin-induced cooperative structural changes in actin 
filaments.  Copolymers of wild type and D11Q mutant actin may be useful 
material in those studies.  Improvements in the methods of fluorescence 
microscopic observation for live imaging of cofilin-actin interactions would 
also lead to useful kinetic and mechanistic insights. 
57 
 
Acknowledgements 
 
I have had great fortune to have interacted with a number of talented 
people during my time in the Uyeda group. 
First and foremost, I wish to thank my advisor, Professor Taro Q. P 
Uyeda, for giving me the opportunity to be here, guidance, advice and 
support.  I could not have achieved this research without his support. 
I wish thank Dr. Nobuhisa Umeki for his help in assays on Asp11 
mutant actins.  I could not have achieved this research without his 
cooperation. 
I wish to thank Dr. Keiko Hirose for her help in electron microscopy.  
I also thank Dr. Kohji Ito for performing nucleotide exchange assay. 
I also thank Dr. Taro Q. P. Noguchi, Dr. Kiyotaka Tokuraku and Dr. 
Akira Nagasaki. They gave me many advices for this research. 
Most importantly, I thank my family for support and encouragement. 
None of this could have been achieved without them. 
  
58 
 
References 
 
Agrawal, P.B., R.S. Greenleaf, K.K. Tomczak, V.L. Lehtokari, C. 
Wallgren-Pettersson, W. Wallefeld, N.G. Laing, B.T. Darras, S.K. 
Maciver, P.R. Dormitzer, and A.H. Beggs. 2007. Nemaline myopathy 
with minicores caused by mutation of the CFL2 gene encoding the 
skeletal muscle actin-binding protein, cofilin-2. Am. J. Hum. Genet. 
80:162-167. 
Agrawal, P.B., M. Joshi, T. Savic, Z. Chen, and A.H. Beggs. 2012. Normal 
myofibrillar development followed by progressive sarcomeric 
disruption with actin accumulations in a mouse Cfl2 knockout 
demonstrates requirement of cofilin-2 for muscle maintenance. Hum 
Mol Genet. 21:2341-2356. 
Aizawa, H., Y. Fukui, and I. Yahara. 1997. Live dynamics of Dictyostelium 
cofilin suggests a role in remodeling actin latticework into bundles. J 
Cell Sci. 110 ( Pt 19):2333-2344. 
Aizawa, H., K. Sutoh, S. Tsubuki, S. Kawashima, A. Ishii, and I. Yahara. 
1995. Identification, characterization, and intracellular distribution of 
cofilin in Dictyostelium discoideum. J Biol Chem. 270:10923-10932. 
An, H.S., and K. Mogami. 1996. Isolation of 88F actin mutants of Drosophila 
melanogaster and possible alterations in the mutant actin structures. 
J. Mol. Biol. 260:492-505. 
Bernstein, B.W., and J.R. Bamburg. 2010. ADF/cofilin: a functional node in 
cell biology. Trends Cell Biol. 20:187-195. 
Blanchoin, L., and T.D. Pollard. 1998. Interaction of actin monomers with 
Acanthamoeba actophorin (ADF/cofilin) and profilin. J. Biol. Chem. 
273:25106-25111. 
Blanchoin, L., and T.D. Pollard. 1999. Mechanism of interaction of 
Acanthamoeba actophorin (ADF/Cofilin) with actin filaments. J Biol 
Chem. 274:15538-15546. 
Bonder, E.M., D.J. Fishkind, and M.S. Mooseker. 1983. Direct measurement 
of critical concentrations and assembly rate constants at the two ends 
of an actin filament. Cell. 34:491-501. 
Bryan, K.E., and P.A. Rubenstein. 2009. Allele-specific effects of human 
deafness gamma-actin mutations (DFNA20/26) on the actin/cofilin 
interaction. J. Biol. Chem. 284:18260-18269. 
59 
 
Burt, C.T., T. Glonek, and M. Barany. 1977. Analysis of living tissue by 
phosphorus-31 magnetic resonance. Science. 195:145-149. 
Butters, C.A., K.A. Willadsen, and L.S. Tobacman. 1993. Cooperative 
interactions between adjacent troponin-tropomyosin complexes may 
be transmitted through the actin filament. J Biol Chem. 
268:15565-15570. 
Carlier, M.F. 1990. Actin polymerization and ATP hydrolysis. Adv Biophys. 
26:51-73. 
Carlier, M.F. 1998. Control of actin dynamics. Curr. Opin. Cell Biol. 10:45-51. 
Carlier, M.F., V. Laurent, J. Santolini, R. Melki, D. Didry, G.X. Xia, Y. Hong, 
N.H. Chua, and D. Pantaloni. 1997. Actin depolymerizing factor 
(ADF/cofilin) enhances the rate of filament turnover: implication in 
actin-based motility. J. Cell Biol. 136:1307-1322. 
Carlier, M.F., and D. Pantaloni. 1988. Binding of phosphate to F-ADP-actin 
and role of F-ADP-Pi-actin in ATP-actin polymerization. J Biol Chem. 
263:817-825. 
Combeau, C., and M.F. Carlier. 1988. Probing the mechanism of ATP 
hydrolysis on F-actin using vanadate and the structural analogs of 
phosphate BeF-3 and A1F-4. J. Biol. Chem. 263:17429-17436. 
Cooke, R. 1975. The role of the bound nucleotide in the polymerization of 
actin. Biochemistry. 14:3250-3256. 
De La Cruz, E.M. 2009. How cofilin severs an actin filament. Biophys Rev. 
1:51-59. 
Drummond, D.R., E.S. Hennessey, and J.C. Sparrow. 1991. Characterisation 
of missense mutations in the Act88F gene of Drosophila melanogaster. 
Mol. Gen. Genet. 226:70-80. 
Egelhoff, T.T., M.A. Titus, D.J. Manstein, K.M. Ruppel, and J.A. Spudich. 
1991. Molecular genetic tools for study of the cytoskeleton in 
Dictyostelium. Methods Enzymol. 196:319-334. 
Fujii, T., A.H. Iwane, T. Yanagida, and K. Namba. 2010. Direct visualization 
of secondary structures of F-actin by electron cryomicroscopy. Nature. 
467:724-728. 
Fujiwara, I., S. Takahashi, H. Tadakuma, T. Funatsu, and S. Ishiwata. 2002. 
Microscopic analysis of polymerization dynamics with individual actin 
filaments. Nat. Cell Biol. 4:666-673. 
Fujiwara, I., D. Vavylonis, and T.D. Pollard. 2007. Polymerization kinetics of 
60 
 
ADP- and ADP-Pi-actin determined by fluorescence microscopy. Proc 
Natl Acad Sci U S A. 104:8827-8832. 
Galkin, V.E., A. Orlova, and E.H. Egelman. 2012. Actin filaments as tension 
sensors. Curr Biol. 22:R96-101. 
Galkin, V.E., A. Orlova, D.S. Kudryashov, A. Solodukhin, E. Reisler, G.F. 
Schroder, and E.H. Egelman. 2011. Remodeling of actin filaments by 
ADF/cofilin proteins. Proc. Natl. Acad. Sci. U. S. A. 108:20568-20572. 
Galkin, V.E., A. Orlova, N. Lukoyanova, W. Wriggers, and E.H. Egelman. 
2001. Actin depolymerizing factor stabilizes an existing state of 
F-actin and can change the tilt of F-actin subunits. J. Cell Biol. 
153:75-86. 
Glotzer, M. 2001. Animal cell cytokinesis. Annu Rev Cell Dev Biol. 17:351-86. 
Goode, B.L., D.G. Drubin, and G. Barnes. 2000. Functional cooperation 
between the microtubule and actin cytoskeletons. Curr Opin Cell Biol. 
12:63-71. 
Graceffa, P., and Dominguez, R. 2003. Crystal structure of monomeric actin 
in the ATP state. Structural basis of nucleotide-dependent actin 
dynamics. J.Biol.Chem. 278:34172-34180. 
Hansen, S.D., A.V. Kwiatkowski, C.Y. Ouyang, H. Liu, S. Pokutta, S.C. 
Watkins, N. Volkmann, D. Hanein, W.I. Weis, R.D. Mullins, and W.J. 
Nelson. 2013. aE-catenin actin-binding domain alters actin filament 
conformation and regulates binding of nucleation and disassembly 
factors. Mol Biol Cell. 24:3710-3720. 
Hatano, S., and F. Oosawa. 1966. Extraction of an actin-like protein from the 
plasmodium of a myxomycete and its interaction with myosin A from 
rabbit striated muscle. J Cell Physiol. 68:197-202. 
Hawkins, M., B. Pope, S.K. Maciver, and A.G. Weeds. 1993. Human actin 
depolymerizing factor mediates a pH-sensitive destruction of actin 
filaments. Biochemistry. 32:9985-9993. 
Hayden, S.M., P.S. Miller, A. Brauweiler, and J.R. Bamburg. 1993. Analysis 
of the interactions of actin depolymerizing factor with G- and F-actin. 
Biochemistry. 32:9994-10004. 
Hendzel, M.J. 2014. The F-act's of nuclear actin. Curr Opin Cell Biol. 
28C:84-89. 
Holmes, K.C., D. Popp, W. Gebhard, and W. Kabsch. 1990. Atomic model of 
the actin filament. Nature. 347:44-49. 
61 
 
Hotulainen, P., E. Paunola, M.K. Vartiainen, and P. Lappalainen. 2005. 
Actin-depolymerizing factor and cofilin-1 play overlapping roles in 
promoting rapid F-actin depolymerization in mammalian nonmuscle 
cells. Mol Biol Cell. 16:649-664. 
Iida, K., K. Moriyama, S. Matsumoto, H. Kawasaki, E. Nishida, and I. 
Yahara. 1993. Isolation of a yeast essential gene, COF1, that encodes a 
homologue of mammalian cofilin, a low-M(r) actin-binding and 
depolymerizing protein. Gene. 124:115-120. 
Johannes, F.J., and D. Gallwitz. 1991. Site-directed mutagenesis of the yeast 
actin gene: a test for actin function in vivo. EMBO J. 10:3951-3958. 
Kabsch, W., H.G. Mannherz, D. Suck, E.F. Pai, and K.C. Holmes. 1990. 
Atomic structure of the actin:DNase I complex. Nature. 347:37-44. 
Kasai, M., S. Asakura, and F. Oosawa. 1962. The G-F equilibrium in actin 
solutions under various conditions. Biochim Biophys Acta. 57:13-21. 
Kitagawa, S., W. Drabikowski, and J. Gergely. 1968. Exchange and release of 
the bound nucleotide of F-actin. Arch. Biochem. Biophys. 125:706-714. 
Kondo, H., and S. Ishiwata. 1976. Uni-directional growth of F-actin. J 
Biochem. 79:159-171. 
Korn, E.D., M.F. Carlier, and D. Pantaloni. 1987. Actin polymerization and 
ATP hydrolysis. Science. 238:638-644. 
Kouyama, T., and K. Mihashi. 1981. Fluorimetry study of 
N-(1-pyrenyl)iodoacetamide-labelled F-actin. Local structural change 
of actin protomer both on polymerization and on binding of heavy 
meromyosin. Eur. J. Biochem. 114:33-38. 
Kudryashov, D.S., E.E. Grintsevich, P.A. Rubenstein, and E. Reisler. 2010. A 
nucleotide state-sensing region on actin. J. Biol. Chem. 
285:25591-25601. 
Laing, N.G., D.E. Dye, C. Wallgren-Pettersson, G. Richard, N. Monnier, S. 
Lillis, T.L. Winder, H. Lochmuller, C. Graziano, S. Mitrani-Rosenbaum, 
D. Twomey, J.C. Sparrow, A.H. Beggs, and K.J. Nowak. 2009. 
Mutations and polymorphisms of the skeletal muscle alpha-actin gene 
(ACTA1). Hum. Mutat. 30:1267-1277. 
Lappalainen, P., and D.G. Drubin. 1997. Cofilin promotes rapid actin 
filament turnover in vivo. Nature. 388:78-82. 
Lazarides, E., and U. Lindberg. 1974. Actin is the naturally occurring 
inhibitor of deoxyribonuclease I. Proc. Natl. Acad. Sci. U. S. A. 
62 
 
71:4742-4746. 
Mabuchi, I. 1981. Purification from starfish eggs of a protein that 
depolymerizes actin. J. Biochem. 89:1341-1344. 
Maciver, S.K., and A.G. Weeds. 1994. Actophorin preferentially binds 
monomeric ADP-actin over ATP-bound actin: consequences for cell 
locomotion. FEBS Lett. 347:251-256. 
Maciver, S.K., H.G. Zot, and T.D. Pollard. 1991. Characterization of actin 
filament severing by actophorin from Acanthamoeba castellanii. J. 
Cell Biol. 115:1611-1620. 
Martonosi, A., M.A. Gouvea, and J. Gergerly. 1960. Studies on actin. I. The 
interaction of C14-labeled adenine nucleotides with actin. J Biol Chem. 
235:1700-1703. 
McGough, A., B. Pope, W. Chiu, and A. Weeds. 1997. Cofilin changes the 
twist of F-actin: implications for actin filament dynamics and cellular 
function. J. Cell Biol. 138:771-781. 
Michelot, A., and D.G. Drubin. 2011. Building distinct actin filament 
networks in a common cytoplasm. Curr Biol. 21:R560-569. 
Miller, B.M., and K.M. Trybus. 2008. Functional effects of nemaline 
myopathy mutations on human skeletal alpha-actin. J. Biol. Chem. 
283:19379-19388. 
Mitchison, T.J., and L.P. Cramer. 1996. Actin-based cell motility and cell 
locomotion. Cell. 84:371-379. 
Miyauchi-Nomura, S., T. Obinata, and N. Sato. 2012. Cofilin is required for 
organization of sarcomeric actin filaments in chicken skeletal muscle 
cells. Cytoskeleton (Hoboken). 69:290-302. 
Monserrat, L., M. Hermida-Prieto, X. Fernandez, I. Rodriguez, C. Dumont, L. 
Cazon, M.G. Cuesta, C. Gonzalez-Juanatey, J. Peteiro, N. Alvarez, M. 
Penas-Lado, and A. Castro-Beiras. 2007. Mutation in the 
alpha-cardiac actin gene associated with apical hypertrophic 
cardiomyopathy, left ventricular non-compaction, and septal defects. 
Eur. Heart J. 28:1953-1961. 
Moon, A.L., P.A. Janmey, K.A. Louie, and D.G. Drubin. 1993. Cofilin is an 
essential component of the yeast cortical cytoskeleton. J Cell Biol. 
120:421-435. 
Morita, H., H.L. Rehm, A. Menesses, B. McDonough, A.E. Roberts, R. 
Kucherlapati, J.A. Towbin, J.G. Seidman, and C.E. Seidman. 2008. 
63 
 
Shared genetic causes of cardiac hypertrophy in children and adults. 
N. Engl. J. Med. 358:1899-1908. 
Muhlrad, A., P. Cheung, B.C. Phan, C. Miller, and E. Reisler. 1994. Dynamic 
properties of actin. Structural changes induced by beryllium fluoride. 
J. Biol. Chem. 269:11852-11858. 
Muhlrad, A., D. Kudryashov, Y. Michael Peyser, A.A. Bobkov, S.C. Almo, and 
E. Reisler. 2004. Cofilin induced conformational changes in F-actin 
expose subdomain 2 to proteolysis. J. Mol. Biol. 342:1559-1567. 
Muhlrad, A., I. Ringel, D. Pavlov, Y.M. Peyser, and E. Reisler. 2006. 
Antagonistic effects of cofilin, beryllium fluoride complex, and 
phalloidin on subdomain 2 and nucleotide-binding cleft in F-actin. 
Biophys. J. 91:4490-4499. 
Murakami, K., T. Yasunaga, T.Q.P. Noguchi, Y. Gomibuchi, K.X. Ngo, T.Q.P. 
Uyeda, and T. Wakabayashi. 2010. Structural basis for actin assembly, 
activation of ATP hydrolysis, and delayed phosphate release. Cell. 
143:275-287. 
Murthy, K., and P. Wadsworth. 2005. Myosin-II-dependent localization and 
dynamics of F-actin during cytokinesis. Curr. Biol. 15:724-731. 
Nakashima, K., N. Sato, T. Nakagaki, H. Abe, S. Ono, and T. Obinata. 2005. 
Two mouse cofilin isoforms, muscle-type (MCF) and non-muscle type 
(NMCF), interact with F-actin with different efficiencies. J. Biochem. 
138:519-526. 
Nishida, E., S. Maekawa, and H. Sakai. 1984. Cofilin, a protein in porcine 
brain that binds to actin filaments and inhibits their interactions with 
myosin and tropomyosin. Biochemistry. 23:5307-5313. 
Noguchi, T.Q.P., R. Toya, H. Ueno, K. Tokuraku, and T.Q.P. Uyeda. 2010a. 
Screening of novel dominant negative mutant actins using glycine 
targeted scanning identifies G146V actin that cooperatively inhibits 
cofilin binding. Biochem Biophys Res Commun. 396:1006-1011. 
Noguchi, T.Q.P., Y. Gomibuchi, K. Murakami, H. Ueno, K. Hirose, T. 
Wakabayashi, and T.Q.P. Uyeda. 2010b. Dominant negative mutant 
actins identified in flightless Drosophila can be classified into three 
classes. J. Biol. Chem. 285:4337-4437. 
Noguchi, T.Q.P., N. Kanzaki, H. Ueno, K. Hirose, and T.Q.P. Uyeda. 2007. A 
novel system for expressing toxic actin mutants in Dictyostelium and 
purification and characterization of a dominant lethal yeast actin 
64 
 
mutant. J. Biol. Chem. 282:27721-27727. 
Oda, T., M. Iwasa, T. Aihara, Y. Maeda, and A. Narita. 2009. The nature of 
the globular- to fibrous-actin transition. Nature. 457:441-445. 
Olson, T.M., V.V. Michels, S.N. Thibodeau, Y.S. Tai, and M.T. Keating. 1998. 
Actin mutations in dilated cardiomyopathy, a heritable form of heart 
failure. Science. 280:750-752. 
Ono, S. 2007. Mechanism of depolymerization and severing of actin filaments 
and its significance in cytoskeletal dynamics. Int Rev Cytol. 258:1-82. 
Ono, S. 2010. Dynamic regulation of sarcomeric actin filaments in striated 
muscle. Cytoskeleton (Hoboken). 67:677-692. 
Orlova, A., and E.H. Egelman. 1997. Cooperative rigor binding of myosin to 
actin is a function of F-actin structure. J. Mol. Biol. 265:469-474. 
Pavlov, D., A. Muhlrad, J. Cooper, M. Wear, and E. Reisler. 2006. Severing of 
F-actin by yeast cofilin is pH-independent. Cell Motil. Cytoskeleton. 
63:533-542. 
Pollard, T.D. 2007. Regulation of actin filament assembly by Arp2/3 complex 
and formins. Annu Rev Biophys Biomol Struct. 36:451-477. 
Pollard, T.D., L. Blanchoin, and R.D. Mullins. 2000. Molecular mechanisms 
controlling actin filament dynamics in nonmuscle cells. Annu Rev 
Biophys Biomol Struct. 29:545-576. 
Riviere, J.B., B.W. van Bon, A. Hoischen, S.S. Kholmanskikh, B.J. O'Roak, C. 
Gilissen, S. Gijsen, C.T. Sullivan, S.L. Christian, O.A. Abdul-Rahman, 
J.F. Atkin, N. Chassaing, V. Drouin-Garraud, A.E. Fry, J.P. Fryns, K.W. 
Gripp, M. Kempers, T. Kleefstra, G.M. Mancini, M.J. Nowaczyk, C.M. 
van Ravenswaaij-Arts, T. Roscioli, M. Marble, J.A. Rosenfeld, V.M. Siu, 
B.B. de Vries, J. Shendure, A. Verloes, J.A. Veltman, H.G. Brunner, 
M.E. Ross, D.T. Pilz, and W.B. Dobyns. 2012. De novo mutations in the 
actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome. Nat 
Genet. 44:440-444, S1-2. 
Romet-Lemonne, G., and A. Jegou. 2013. Mechanotransduction down to 
individual actin filaments. Eur J Cell Biol. 92:333-338. 
Schoenenberger, C.A., H.G. Mannherz, and B.M. Jockusch. 2011. Actin: from 
structural plasticity to functional diversity. Eur J Cell Biol. 
90:797-804. 
Sharma, S., E.E. Grintsevich, C. Hsueh, E. Reisler, and J.K. Gimzewski. 
2012. Molecular cooperativity of drebrin1-300 binding and structural 
65 
 
remodeling of F-actin. Biophys J. 103:275-283. 
Shu, X., N.C. Shaner, C.A. Yarbrough, R.Y. Tsien, and S.J. Remington. 2006. 
Novel chromophores and buried charges control color in mFruits. 
Biochemistry. 45:9639-9647. 
Solomon, T.L., L.R. Solomon, L.S. Gay, and P.A. Rubenstein. 1988. Studies on 
the role of actin's aspartic acid 3 and aspartic acid 11 using 
oligodeoxynucleotide-directed site-specific mutagenesis. J. Biol. Chem. 
263:19662-19669. 
Spudich, J.A., and S. Watt. 1971. The regulation of rabbit skeletal muscle 
contraction.  I. Biochemical studies of the interaction of the 
tropomyosin-troponin complex with actin and the proteolytic 
fragments of myosin. J. Biol. Chem. 246:4866-4871. 
Sternlicht, H., G.W. Farr, M.L. Sternlicht, J.K. Driscoll, K. Willison, and M.B. 
Yaffe. 1993. The t-complex polypeptide 1 complex is a chaperonin for 
tubulin and actin in vivo. Proc. Natl. Acad. Sci. U. S. A. 90:9422-9426. 
Straub, F.B. 1942. Actin. Studies from the Institute of Medical Chemistry 
University Szeged. 2:3-15. 
Strohman, R.C. 1959. Studies on the enzymic interactions of the bound 
nucleotide of the bound nucleotide of the muscle protein actin. 
Biochim Biophys Acta. 32:436-449. 
Strzelecka-Golaszewska, H. 1973. Effect of tightly bound divalent cation on 
the equilibria between G-actin-bound and free ATP. Eur J Biochem. 
37:434-440. 
Suarez, C., J. Roland, R. Boujemaa-Paterski, H. Kang, B.R. McCullough, A.C. 
Reymann, C. Guerin, J.L. Martiel, E.M. De la Cruz, and L. Blanchoin. 
2011. Cofilin tunes the nucleotide state of actin filaments and severs 
at bare and decorated segment boundaries. Curr Biol. 21:862-868. 
Theriot, J.A., and T.J. Mitchison. 1991. Actin microfilament dynamics in 
locomoting cells. Nature. 352:126-131. 
Theriot, J.A., T.J. Mitchison, L.G. Tilney, and D.A. Portnoy. 1992. The rate of 
actin-based motility of intracellular Listeria monocytogenes equals 
the rate of actin polymerization. Nature. 357:257-260. 
Tokuraku, K., R. Kurogi, R. Toya, and T.Q.P. Uyeda. 2009. Novel mode of 
cooperative binding between myosin and Mg2+ -actin filaments in the 
presence of low concentrations of ATP. J Mol Biol. 386:149-162. 
Tsaturyan, A.K., N. Koubassova, M.A. Ferenczi, T. Narayanan, M. Roessle, 
66 
 
and S.Y. Bershitsky. 2005. Strong binding of myosin heads stretches 
and twists the actin helix. Biophys. J. 88:1902-1910. 
Tsujioka, M., S. Yumura, K. Inouye, H. Patel, M. Ueda, and S. Yonemura. 
2012. Talin couples the actomyosin cortex to the plasma membrane 
during rear retraction and cytokinesis. Proc Natl Acad Sci U S A. 
109:12992-12997. 
Uyeda, T.Q.P., Y. Iwadate, N. Umeki, A. Nagasaki, and S. Yumura. 2011. 
Stretching actin filaments within cells enhances their affinity for the 
myosin II motor domain. PLoS One. 6:e26200. 
van den Ent, F., L. Amos, and J. Lowe. 2001. Bacterial ancestry of actin and 
tubulin. Curr Opin Microbiol. 4:634-638. 
van Wijk, E., E. Krieger, M.H. Kemperman, E.M. De Leenheer, P.L. Huygen, 
C.W. Cremers, F.P. Cremers, and H. Kremer. 2003. A mutation in the 
gamma actin 1 (ACTG1) gene causes autosomal dominant hearing loss 
(DFNA20/26). J. Med. Genet. 40:879-884. 
Volkmann, N., D. DeRosier, P. Matsudaira, and D. Hanein. 2001. An atomic 
model of actin filaments cross-linked by fimbrin and its implications 
for bundle assembly and function. J Cell Biol. 153:947-956. 
Wegner, A. 1976. Head to tail polymerization of actin. J Mol Biol. 108:139-50. 
Wegner, A. 1977. The mechanism of ATP hydrolysis by polymer actin. 
Biophys Chem. 7:51-58. 
Wertman, K.F., D.G. Drubin, and D. Botstein. 1992. Systematic mutational 
analysis of the yeast ACT1 gene. Genetics. 132:337-350. 
Williams, S.P., A.M. Fulton, and K.M. Brindle. 1993. Estimation of the 
intracellular free ADP concentration by 19F NMR studies of 
fluorine-labeled yeast phosphoglycerate kinase in vivo. Biochemistry. 
32:4895-4902. 
Woodrum, D.T., S.A. Rich, and T.D. Pollard. 1975. Evidence for biased 
bidirectional polymerization of actin filaments using heavy 
meromyosin prepared by an improved method. J Cell Biol. 67:231-237. 
Yonezawa, N., E. Nishida, and H. Sakai. 1985. pH control of actin 
polymerization by cofilin. J. Biol. Chem. 260:14410-14412. 
Yount, R.G., D. Babcock, W. Ballantyne, and D. Ojala. 1971. Adenylyl 
imidodiphosphate, an adenosine triphosphate analog containing a 
P--N--P linkage. Biochemistry. 10:2484-2489. 
Yumura, S., H. Mori, and Y. Fukui. 1984. Localization of actin and myosin for 
67 
 
the study of ameboid movement in Dictyostelium using improved 
immunofluorescence. J Cell Biol. 99:894-899. 
Zak, R., A.F. Martin, G. Prior, and M. Rabinowitz. 1977. Comparison of 
turnover of several myofibrillar proteins and critical evaluation of 
double isotope method. J. Biol. Chem. 252:3430-3435. 
Zhu, M., T. Yang, S. Wei, A.T. DeWan, R.J. Morell, J.L. Elfenbein, R.A. Fisher, 
S.M. Leal, R.J. Smith, and K.H. Friderici. 2003. Mutations in the 
gamma-actin gene (ACTG1) are associated with dominant progressive 
deafness (DFNA20/26). Am. J. Hum. Genet. 73:1082-1091. 
 
 
 
